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Abstract 
Homeostasis is an indispensable phenomenon in the maintenance of living 
organisms. Genetic defects which disrupt negative feedback processes can 
impact homeostatic regulation, potentially resulting in disease. To uncover the 
molecular mechanisms governing these and other diseases potentially related to 
defective homeostasis, I used the Drosophila neuromuscular junction as a model 
system. I characterized two potential mechanisms that regulate homeostasis 
within the nervous system. First, in Drosophila larval motor neurons, ligand 
activation of Drosophila metabotropic glutamate receptor A (DmGiuRA) mediates 
a Phosphoinositide 3-kinase (PI3K)-dependent downregulation of neuronal 
activity, but the mechanism by which mGiuR activates PI3K remains incompletely 
understood. Here, I identified Ca2+/Calmodulin-dependant protein kinase II 
(CaMKII) and the Focal adhesion kinase (DFak) as critical intermediates in the 
DmGiuRA-dependent activation of PI3K at Drosophila motor nerve terminals. I 
found that transgene-induced CaMKII inhibition or the DFaf<CG1 null mutation each 
block the ability of glutamate application to activate PI3K in larval motor nerve 
terminals, whereas transgene-induced CaMKII activation increases P13K activity 
II 
in motor nerve terminals in a DFak-dependent manner, even in the absence of 
glutamate application. I conclude that the activation of PI3K by DmGiuRA is 
mediated by CaMKII and DFak. Second, I observed that Push, a putative 
E3-ubiquitin ligase and Ca2+fCalmodulin binding protein, regulates both 
neurotransmitter release and retrograde signaling in the Drosophila 
neuromuscular junction. I found that RNAi-mediated Push inhibition in the neuron 
increases but, in the muscle decreases, neurotransmitter release. Similar results 
were obtained from RNAi knock down of PLCJ3 and IP3R, which mediates Ca2+ 
release from the endoplasmic reticulum. I conclude that Push mediation of the 
ubiquitin proteasome system may be important in the regulation of PLC J3 
/IP3R-mediated intracellular Ca2+ release, and that this Ca2+ release in the neuron 
inhibits neurotransmitter release, but in the muscle activates neurotransmitter 
release via a retrograde signal. 
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Chapter 1 : Introduction 
1.1 Significance 
Homeostatic regulation has been observed as a response to maintain the 
proper function of the nervous system. When a system under homeostatic 
regulation is perturbed, neuronal physiology, including synaptic function and 
cellular depolarization, will be altered to compensate for the changes (Davis and 
Goodman, 1998; Desai et al., 1999). However, if balance cannot be restored, the 
result might be neurological disease, such as autism, epilepsy, and schizophrenia. 
In addition, the defects of Phosphatidylinositol 3-kinases (PI3K) and type II 
metabotropic glutamate receptors (mGiuR) have been implicated in causing these 
neurological diseases (Kwon et al., 2006; Li et al., 2002; Ogawa et al., 2007; 
Schoepp, 2001 ). The observation that altered PI3K or mGiuR activity might 
underlie these diseases raised the possibility that these molecules might 
participate in homeostatic regulation. If so, our research on mGiuR/PI3K 
feedback-associated homeostatic signaling can further elucidate the linkage 
between PI3K/mGiuR activity and physiological responses. This study may also 
be able to assist with the development of new therapeutic strategies for treating 
these neurological diseases. 
1.2 Homeostasis and negative feedback control in neuronal systems 
Homeostasis is an internal equilibrium mechanism that maintains and adjusts 
physiological processes in the living organism. In the nervous system, 
homeostatic signaling also controls and maintains the stability of neuronal 
excitability and growth (Marder and Prinz, 2002; Turrigiano and Nelson, 2004). 
The nervous system can be treated as a complicated electrical circuit. When this 
circuit is simplified, the whole circuit can be divided into three parts: inward signal, 
outward signal, and integrative feedback; further, the outward signal contains the 
set point output and actual output (Figure 1.2.1) (Yi et al., 2000). In a perfectly 
controlled circuit system, the input will be equal to the set point output. However, 
in the nervous system, exogenous factors such as nutritional and genetic inputs, 
cause signal error (Davis, 2006a). The difference between actual output and set 
point output signal system utilizes integrative feedback to rectify this error. 
Recently, two different types of mechanisms have been proposed to control 
2 
neuronal homeostasis by maintaining a neuron's intrinsic electrical properties. 
First, activity-independent coupled expression regulates the homeostasis of 
excitability through the expression, posttranslational processing, or modification of 
ion channels (MacLean et al., 2005). 
Gain 
Negative 
'-----1 Feedback .--------~ 
Figure 1.2.1 : The block diagram of integrative feedback control circuit can 
represent the environment for controlling proper neuronal homeostasis in the 
nervous system. The synaptic microenvironment can be described as circuit. 
When the neurotransmitters are released from presynaptic area (input signal) the 
postsynaptic region (gain) will relay and amplify the signal (output signal). 
However, if the output signal is not equal as set point output, the error will be 
generated; furthermore, the negative feedback will adjust the presynaptic input to 
rectify the error and maintain proper homeostasis. 
Second, negative feedback can be triggered by signaling molecules that 
3 
sense neuron firing, which maintain homeostasis through transcriptional and 
translational regulatory machinery. This is also called activity-dependent 
regulation (Davis and Bezprozvanny, 2001; Desai et al., 1999). These 
phenomena provide us with starting points to study neuronal homeostasis. 
1.3 Action potential propagation and synaptic transmission 
1.3.1 The biophysical properties of passive neuronal membrane and resting 
potential 
The cell membrane is a specialized structure that separates the internal 
environment from the outside environment. The membrane is composed of a 
phospholipid bilayer and embedded proteins. The phospholipids are bipolar 
organic molecules which contain hydrophobic "tail" regions and hydrophilic "head" 
regions. These amphipathic phospholipids will form a continuous lipid bilayer and 
the arrangement of phospholipids in the lipid bilayer results in very low 
permeability to polar solutes. This resting potential of the passive neuronal 
membrane is determined by the most permenable ion, uaually K+. In neurons, the 
4 
resting potential is generated by the distribution of three major ions, which are 
potassium (K+), sodium (Na+), and chloride (CI-). These ions all have different 
distributions across the membrane. For example, in mammalian spinal motor 
axon, the electrochemical potential of K+ across a semi-permeable membrane 
can be derived using the Nernst Equation (Equation 1.3.1 ). Based on this 
equation, the Nernst potential of K+ is -90 mV (Ganong WF, 2005). 
E = RT 1 [Ion lextracellular (Equation 1.3.1) 
um ZF n [Ion]intracelluar 
R =universal gas constant 
T = absolute temperature 
Z =valence 
F =Faraday constant 
m Extra Celular Fluid (mM) 
Potassium (K+) 5.5 
Sodium (Na+) 150.0 
Chloride (0-) 125.0 
Intra Cellular Ruid (mM) 
150.0 
15.0 
9.0 
Nemst Potential (mV) 
-90 
60 
-70 
Table 1.3.1. Extracellular and intracellular ionic distribution of the major ions 
across the passive neuronal membrane of the mammalian spinal motor axon 
(Moore and Adelman, 1961, Ganong WF, 2005). 
5 
In addition, the individual electrochemical potentials and the permeability of 
each of the relevant ion species (K+, Na+, and Cl-) can be used for calculating the 
actual resting membrane potential inside the neurons. The mathematical model 
which is used to describe the resting membrane potential is 
Goldman-Hodgkin-Katz voltage equation (Equation 1.3.2). Based on this equation 
and the different distributions of K+, Na+, and Cl- across the membrane of 
mammalian spinal motor axon, the resting potential is -70 mV (Ganong WF, 
2005). 
Vm = RT ln Pk[K+l, +PNJNa+l, +PcJCI-]i (Equation 1.3.2) 
ZF Pk[K+]i+PNJNa+]; +Pc:1[Cr] 0 
P= permeability 
R = universal gas constant 
T = absolute temperature 
Z =valence 
F =Faraday constant 
1.3.2 Action potential propagation 
In the absence of perturbations, the neurons are typically maintained at a 
negative resting potential. When synaptic inputs stimulate at the hillock which is 
6 
part of the cell body of neuron and connects to the axon, a small depolarization of 
the membrane will be generated. If this small depolarization is successfully above 
the stimulation threshold (minimum membrane potential for inducing action 
potential), it will initiate the opening of voltage-gated Na+ channels which allow 
Na+ ions to flow into the cell, thus resulting in further depolarization of the 
membrane potential (Figure 1.3.1 ). Subsequently, the depolarization spreads 
outwards from the local region and triggers the opening of other voltage-gated 
Na+ channels as a positive feedback to create the continuous wave of 
depolarization moving down to the axon terminal. Following depolarization of the 
membrane, the opening of voltage-gated K+ channels occurs and increases 
permeability of K+ ions to flux from the intracellular region. Once Na+ influx 
reaches the maxima (the peak of action potential) (Figure 1.3.1 ), K+ efflux then 
repolarizes the cell (Figure 1.3.1 ). A hyperpolarization of the membrane potential 
subsequently occurs, which is caused by an excess of K+ efflux (Figure 1.3.1 ). To 
reset the membrane potential back to equilibrium, Na+ and K+ channels close and 
Na+fK+ pumps utilize ATP as energy source to transport Na+ and K+ acrossing 
membrane. 
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Figure 1.3.1: The mechanism of action potential propagation. (1) Resting state: 
Both [Na+] and [K+] across the membrane maintain the resting potential. (2) 
Depolarization: the electrical signal triggers Na+ channel opening. The Na+ enters 
the intracellular region and increases the Na+ concentration. (3) Rising Phase: 
more Na+ channels open and allow more Na+ to flow into intracellular region. The 
[Na+] increase results in further depolarization. This stage also initiates K+ channel 
opening. (4) Falling phase: the Na+ channels begin to close and K+ start to leave 
cell via K+ channels. (5) Hyperpolarization: extra K+ release from the intracellular 
to extracellular. K+ channels begin to close. (6) Back to resting state: both Na+ and 
K+ channels close and Na+fK+ pumps utilize ATP as energy source to transport 
Na+ and K+ acrossing membrane and reset the membrane potential back to 
equilibrium. 
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1.3.3 Neurotransmitter release 
When the action potential reaches to the nerve terminal, the depolarization 
triggers the opening the voltage-gated Ca2+ channels and allows the Ca2+ to flow 
from extracellular regions into the axon terminal (Figure 1.3.2). The increase of 
[Ca2+] induces the vesicles containing either excitatory or inhibitory 
neurotransmitter to release from the active zone into the synapse. The released 
neurotransmitters diffuse across the synaptic cleft and bind to target receptors on 
the postsynaptic region of the target dendrite or muscle (Figure 1.3.2). In 
summary, these electrical and chemical changes in the nervous system provide 
the powerful machinery needed to control communication among tissues inside 
living organisms. 
9 
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Figure 1.3.2. The mechanism of neurotransmitter release in the neuromuscular 
junction. (1) The action potential travels to the presynaptic area of neuromuscular 
junction and triggers opining of voltage-gated Ca2+ channels. (2) The opened Ca2+ 
channels allow Ca2+ flux into the nerve terminal and increases Ca2+ concentration. 
(3) The increased [Ca2+] initiates the membrane fusion process mediated by V-
and T-SNAREs. (4) The neurotransmitters are released into the synaptic cleft by 
exocytosis. (5) The neurotransmitters diffuse and bind to target receptors and 
induce responses. 
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1.4 Neurological disorders involving mGiuR/PI3K-mediated homeostatic 
defects 
Metabotropic glutamate receptors (mGiuRs), which are G protein coupled 
receptors for which glutamate is ligand, mediate aspects of synaptic plasticity in 
mammalian and invertebrate systems. In several regions of the mammalian brain, 
including the hippocampus, the cerebellum, the prefrontal cortex and others, 
ligand activation of group I mGiuRs induces a long-term depression of synaptic 
activity, termed mGiuR-mediated LTD (Luscher and Huber, 201 0). Induction of 
mGiuR-mediated LTD both activates and requires the activation of the lipid kinase 
P13 Kinase (PI3K) and the downstream kinase Tor (Hou and Klann, 2004). 
Several genetic diseases of the nervous system are predicted to increase 
sensitivity to activation of mGiuR-mediated LTD. For example, increased 
sensitivity to induction of mGiuR-mediated LTD has been observed in the mouse 
model for Fragile X (Bear et al., 2004). Furthermore, the genes affected in 
tuberous sclerosis (Tsc1 and Tsc2) and Neurofibromatosis (Nf1) encode proteins 
that downregulate Tor activity (Dasgupta et al., 2005; Gao et al., 2002). These 
observations raise the possibility that hyperactivation of mGiuR-mediated LTD 
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plays a causal role in the neurological phenotypes of Fragile X, Neurofibromatosis 
and tuberous sclerosis (Kelleher and Bear, 2008). Because these diseases are 
each associated with an extremely high incidence of autism spectrum disorders 
(ASD), and because several lines of evidence suggest that elevated PI3K activity 
is associated with ASD (Cusco et al., 2009; Kwon et al., 2006; Mills et al., 2007; 
Serajee et al., 2003), it has been hypothesized that hyperactivation of this 
pathway might be responsible for ASD as well. 
1.5 mGiuR/PI3K-dependant signal transduction pathway 
Glutamate is the major excitatory neurotransmitter in the mammalian central 
nervous system (CNS) and at the insect neuromuscular junction (NMJ) (Jan and 
Jan, 1976), and activates two distinct types of receptors; ion-channel-associated 
(ionotropic) and G-protein-coupled (metabotropic) glutamate receptors (Enz, 
2007). The N-terminal domain of mGiuR is located in the extracellular region and 
is about 600 amino acids long. In mammals, there are eight mGiuR subtypes 
divided into three groups, which each activate different downstream signaling 
pathways (Enz, 2007). Previous work demonstrated that the C-terminal domains 
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vary in length (Enz, 2007). The C-termini are the key sites for interaction with 
different proteins to regulate different signaling pathways (Perroy et al., 2001). 
PI3K is a conserved lipid kinase that contains two subunits and mediates several 
physiological functions, including cell survival, cell cycle progression, protein 
synthesis, and aging (Engelman et al., 2006). PI3K is activated most prominently 
by receptor tyrosine kinases. PI3K phosphorylates phosphatidylinositol-
3,4-bisphosphate (PIP2) to phosphatidyl-inositol-3,4,5-triphosphate (PIP3). As 
mentioned in section 1.4, mGiuR has been implicated in the activation of 
PI3K-mediated signaling pathways (Hou and Klann, 2004). When PIP3 is present 
on the membrane, the pleckstrin homolgy domain containing proteins, which can 
bind phosphatidylinositol lipids, phosphoinositide-dependent protein kinase-1 
(PDK1) and protein kinase 8 (PKB/AKT), are recruited to the membrane, and AKT 
is phosphorylated by PDK1. The phospho-AKT then regulates through 
phosphorylation many downstream effectors, such as the forkhead box 
transcription factor FOXO, mammalian target of rapamycin (mTOR), and 56 
kinase (S6K). These downstream effectors can further control different 
physiological functions (Engelman et al., 2006) (Figure 1.5.1 ). Foxo has been 
implicated in the regulation of cell survival (Burgering and Medema, 2003) and 
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S6K is an important factor in controlling protein synthesis and cell growth (Klann 
and Sweatt, 2008). 
In addition, the phosphatase and tensin homologue deleted on 
chromosome1 0 (PTEN) function as a negative effector, to dephosphorylate PIP3 
to PIP2 and inhibit the activation of PI3K. PTEN has two structural domains; the 
phosphatase and C2 domains. The phosphatase domain of PTEN can 
dephosphorylate PIP3 to PIP2. Therefore, PI3K and PTEN can function together 
to adjust PIP3 levels and maintain proper level of AKT-mediated signaling 
(Gericke et al., 2006) (Figure 1.5.1). In conclusion, the mGiuR/PI3K signaling 
pathway has important roles in the regulation of synaptic plasticity and neuronal 
homeostasis. Therefore, the mGiuR/PI3K-mediated signaling pathway becomes 
one key mechanism to understand the cause of ASD, Fragile X, 
Neurofibromatosis and tuberous sclerosis 
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Figure 1.5.1. The PI3K signaling pathway regulates many physiological events by 
interacting with different downstream effectors. PI3K can be activated by 
different types of upstream receptors including tyrosine kinase receptors and 
GPCRs. Active PI3K phosphorylates PIP2 to PIP3. Next, PIP3 recruits PDK1 and 
AKT and PDK1 phosphorylates AKT (p-AKT). The p-AKT further regulates 
downstream effectors, such as Foxo and S6K, to control cell survival and cell 
growth, respectively. 
1.6 Drosophila GAL4/UAS system 
Drosophila GAL4/UAS system is a genetic tool to express genes temporally 
and spatially. GAL4 is a protein containing 881 amino acids and first identified in 
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Saccharomyces cerevisiae. GAL4 is a transcriptional activator and regulates 
transcription by directly binding to a specific DNA sequence called upstream 
activation sequence (UAS) (Giniger et al., 1985). Molecular biological and 
transgenic methodologies are used to create the transgenic flies that carry either 
ga/4 or target genes sequence downstream of UAS into the Drosophila genome 
randomly. To active specific UAS target gene transcription, GAL4 fly lines (also 
called drivers), which are under control of tissue specific promoters, will mate with 
responder lines (which call UAS-drives transgenes) to express target genes 
(Figure 1.6.1 ). The expression patterns of target genes will reflect the GAL4 
pattern of the respective driver (McGuire et al., 2004; Phelps and Brand, 1998). 
Because of these special characters of the Gai4/UAS system, we can study the 
molecular mechanism of nervous system by expressing the target proteins and 
measuring the change of neurological properties. 
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Figure 1.6.1. The Drosophila GAL4/UAS system. Flies carrying yeast transcription 
factor Gal4 with a specific expression pattern are crossed to flies carrying target 
genes under the control of UAS (UAS-target gene). The progeny will carry both 
Gal4 and UAS-target gene and express target gene in the expression pattern of 
the Gal4. (Fly pictures are generously provided by Cassidy Johnson) 
1. 7 Drosophila larval nervous system for studying neuronal function. 
Drosophila melanogaster is a simple and popular genetic model system for 
biological studies, including aging, growth, and neuroscience. There are several 
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advantages in using Drosophila for neuronal studies. The Drosophila genome and 
gene variations are simple compared to vertebrate systems. Drosophila gene 
expression can be easily manipulated both spatially and temporally. The anatomy 
of the Drosophila neuromuscular system is very well-understood. Drosophila is a 
proven system for the study of electrophysiology, development, and behavior (Jan 
and Jan, 1976; Jan and Jan, 1978; Mackay, 2009). In addition, only a few motor 
neurons innervate Drosophila body wall muscles, and synapses are accessible 
for both physiological and developmental studies (Budnik et al., 1990). The 
synapses, also called boutons, in the NMJ develop during late embryonic stages 
and then grow significantly during larval development (Prokop, 2006). The 
neuronal growth exhibits increases in branching, bouton number, and active 
zones per bouton (Marques et al., 2002). In summary, the Drosophila larva 
provides a great platform to study electrophysiology and growth in motor neurons. 
1.8 Excitatory junction potential {EJP) as a reflection for measuring Drosophila 
neurotransmitter release. 
As mentioned in Section 1.3.3, an action potential is propagated to the nerve 
18 
terminal and causes transmitter release at the neuromuscular junction. The 
neurotransmitter subsequently induces the depolarization of the muscle 
membrane, called the excitatory junction potential (EJP) (Jan and Jan, 1976). EJP 
amplitude can represent the amount of transmitter release. In addition, at low 
[Ca2+), Ca2+ is limiting for transmitter release, and mutations that alter Ca2+ influx 
have significant effects on EJP amplitude (Ganetzky and Wu, 1982; Huang and 
Stern, 2002). For example, increasing the activity of Phosphatidylinositol 3-kinase 
(PI3K) attenuates the amount of neurotransmitter release and results in a 
decrease in EJP amplitude (Howlett et al., 2008), whereas decreasing the activity 
of PI3K increases the amount of neurotransmitter release and results in an 
increase in EJP amplitude (Howlett et al., 2008). Therefore, measuring EJP 
amplitude within genotypes that have altered neurotransmitter release could 
provide information to elucidate the signaling pathways that regulate neuronal 
activity. 
1.9 Long term facilitation (L TF} as a reflection for measuring Drosophila 
neuronal excitability 
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L TF is a form of synaptic plasticity induced when a larval motor neuron is 
subjected to a train of repetitive nerve stimulations at low external [Ca2+]. At a 
certain point during the stimulus train, a threshold is reached, and subsequent 
stimulations elicit EJPs greatly increased in amplitude and duration. This 
facilitation (termed L TF) results from increased and asynchronous 
neurotransmitter release, which in turn results from increased duration of nerve 
terminal depolarization (Jan and Jan, 1978). The number of stimulations required 
to reach this L TF threshold (L TF onset rate) is decreased by increased neuronal 
excitability (Jan and Jan, 1978; Mallart et al., 1991; Poulain et al., 1994; Schweers 
et al., 2002; Stern and Ganetzky, 1989; Stern et al., 1990). For example, 
manipulation of molecules that increase activities of K+ channel, such as 
Hyperkinetic (Hk) and ether-a-go-go (eag) or decrease activities of Na+ channel, 
such as paralytic (para) decreases the rate of onset of L TF (Figure 1.9.1 ). This 
phenomenon is defined as hypoexcitability (Figure 1.9.1 ). In contrast, 
manipulation of molecules that decrease activities of K+ channel or increase 
activities of Na+ channel decrease the rate of onset of L TF. This phenomenon is 
defined as hyperexcitability (Figure 1.9.1) (Card nell et al., 2006; Stern and 
Ganetzky, 1989; Stern et al., 1990). By measuring LTF onset rate, the genotypes 
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that reveal either hyperexcitability or hypoexcitability could provide information to 
map the signaling pathways that regulate neuronal activity. 
Hyperexcitable Mutants 
(fast facilitating} 
\ i . 
1
5mV 
l __ 
200 msec 
Hypoexcitable Mutants 
(Slow facilitating) 
Figure 1.9.1. Drosophila neuronal excitability. L TF is elicited by applying 
high-frequency stimulus train (1 0 Hz in this figure) at low external [Ca2+]. 
Hyperexcitability is defined as an increase in the rate of onset of L TF. On the 
contrary, hypoexcitability is defined as a decrease of the rate of onset of L TF 
(image is adopted and modified from Doctoral thesis of Eric Howlett). 
Based on this phenomenon in Drosophila nervous system, the Parmentier 
lab first reported that elimination of Drosophila mGiuR (DmG/uRA) by the null 
mutation DmG!uRA112b, or by RNAi-mediated DmG!uRA knockdown specifically in 
motor neurons, increases neuronal excitability (Bogdanik et al., 2004). DmGiuRA 
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is required for the regulation of neuronal excitability and presynaptic growth 
(Bogdanik et al., 2004). Later, our lab found that the mGiuR-associated PI3K/AKT 
signaling pathway is a negative feedback to maintain homeostasis in the 
glutamatergic synapse (Howlett et al., 2008). Our data provided several 
evidences. First, DmG!uRA112b and the inhibition of PI3K pathway by motor 
neuron-specific overexpression of either the phosphatase PTEN, which opposes 
the effect of PI3K, or the dominant-negative P/3K (P/3J<DN) increased the rate of 
onset of L TF. Second, the constitutive activation of PI3K and elimination of 
transcription factor Foxo by Foxo null mutation (Foxo21/Foxo25) both decreases 
neuronal excitability. Third, DmG!uRA112b blocked the elevation of phospho-AKT 
during the glutamate application. Finally, the dominant-negative S6K(S6J<DN), a 
downsteam signal molecule of PI3K/AKT, prevented the constitutive activation of 
PI3K inducing neuronal overgrowth (Howlett et al., 2008). Therefore, the defect of 
DmG!uRA increased motor neuron excitability via PI3K and the downstream 
FOXO and decreased neuronal arborization via PI3K and the downstream the 
S6K (Figure 1.9.2) (Howlett et al., 2008). Even though mGiuR, PI3K and 
downstream effectors, which are involed in the regulation of neuronal excitability 
and growth, are characterized, the molecular intermediates in the communication 
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between mGiuR and PI3K, and between Foxo and target genes remained 
unidentified. 
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Figure 1.9.2: A proposed mechanism for the DmGiuRA-dependent activation of 
PI3K. We suggest that glutamate released from motor nerve terminals as a 
consequence of neuronal activity activates DmGiuRA autoreceptors located in 
motor nerve terminals. PI3K activation decreases neuronal excitability by 
inhibiting the transcription factor Foxo, and increases synapse number by 
activating S6 kinase. 
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1.1 0 Drosophila retrograde signaling at the neuromuscular junction 
In the Drosophila neuromuscular junction (NMJ), three basic events have 
been observed to enable maintenance of neuronal homeostasis. First, 
anterograde communication, such as action potential propagation and 
neurotransmitter release, directly controls the change of membrane potential and 
vesicle release (see section 1.3) (Marques, 2005). Second, presynaptic negative 
feedback regulation, such as mGiuR/PI3K-mediated negative feedback, adjusts 
the neuronal excitability and transmitter release (see section 1.5) (Bogdanik et al., 
2004; Howlett et al., 2008). This negative feedback-mediated inhibition can be in 
response to excessive vesicle release at motor nerve terminal and reset the 
system (Davis, 2006b). Third, post-synaptic retrograde signaling, such as TGF-~ 
signaling-mediated retrograde signaling, affects and regulates pre-synaptic 
neurotransmitter release. This effect of post-synaptic retrograde signaling will be 
described in detail in this section (Koh et al., 2000; Marques, 2005; Marques et al., 
2002). 
TGF-~-mediated retrograde signaling is a well-understood mechanism which 
controls the number of vesicle release (also called quantal content) at Drosophila 
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NMJ (Marques, 2005; Marques et al., 2002; McCabe et al., 2003). The process of 
retrograde signaling initiates with the secretion of Glass bottom boat {Gbb), a 
bone morphogenetic protein and the ligand of TGF beta type II receptors, from the 
muscle (McCabe et al., 2003). Gbb diffuses from the muscle site (post-synaptic) 
to the nerve terminal (pre-synaptic) and binds to the type II receptor Wishful 
thinking (Wit) at the nerve terminal (Aberle et al., 2002; McCabe et al., 2004; 
McCabe et al., 2003; Rawson et al., 2003); moreover, this binding event induces 
the Ser/Thr kinase activity of Wit (Figure 1.1 0.1 ). This Gbb/Wit binding complex 
recruits and phosphorylates one of the type I receptors, either Saxophone (Sax) 
or Thickveins {Tkv) (Rawson et al., 2003). The phosphorylation of Sax or Tkv 
activates their own kinase activities, and then phosphorylates the presynaptic 
transcription factor Mad (Aberle et al., 2002; Marques et al., 2002). Following 
phosphorylation, phospho-Mad transports from the axon terminal to the nucleus 
and forms a complex with the co-Smad Medea (Med) (Aberle et al., 2002; 
Marques et al., 2002). This active transcription factor complex then modulates the 
expression of target genes and adjusts the quantal content of transmitter release 
(Figure 1.1 0.1) (Aberle et al., 2002; Marques et al., 2002; McCabe et al., 2004; 
McCabe et al., 2003; Rawson et al., 2003). 
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However, several lines of evidence have shown that TGF-~-mediated 
retrograde signaling is not the sole pathway to control the retrograde signaling in 
the Drosophila NMJ. In Drosophila, cell adhesion molecules, such as homophilic 
cell adhesion molecule Fasciclin II (Fasll) are required for retrograde signaling 
(Kazama et al., 2007). They reported that postsynaptic overexpession of 
constitutive calcium/calmodulin-dependent protein kinase II (CaMKII) induced the 
retrograde signaling by increasing the number of active zones, and the frequency 
of miniature excitatory junction currents (mEJCs) but these CaMKII-mediated 
retrograde signaling were blocked in fas/1 mutation backgrounds (Kazama et al., 
2007). The results suggested that the modulation of retrograde signaling is 
initiated by CaMKII and independent of the TGF-~ signaling-mediated retrograde 
signaling (Kazama et al., 2007). However, the microenvironmental changes 
including the alteration of cell adhesion still remain unclear. Therefore, the 
examination of cell adhesion in the regulation of retrograde signaling is also 
important for understanding the neuronal homeostasis. 
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Figure 1.1 0.1. A TGF-~ signaling pathway regulates retrograde signaling in the 
Drosophila NMJ. Gbb is secreted from muscle (post-synaptic) and then diffuses to 
the nerve terminal (pre-synaptic). Once Gbb binds to TGF beta type II receptor 
(Wit), Wit will recruit and activate the TGF beta type II receptor (Sax or Tkv). 
Furthermore, the activation of Sax of Tkv will regulate the activity of the 
transcription factor complex (Mad and Med) and control neurotransmitter release 
in the nerve terminal. 
1.11 Structure and function of Ca2+/Calmodulin protein kinase II 
1.11.1 The role of Calcium in cells 
Calcium (Ca2+) is a key element regulating a large number of intracellular 
responses, including glycogenolysis, endocytosis, mitochondrial respiration, 
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transcription, and neurotransmitter release (Hudman and Schulman, 2002). 
Ca2+ also acts as a second messenger. When membrane receptors are activated 
by outside signal molecules, including hormones and neurotransmitters, these 
active membrane receptors couple to second messengers and convey the 
extracellular stimuli with correspondent cellular responses (Hudman and 
Schulman, 2002). The signaling processes that are mediated by Ca2+ are 
essential for neuron physiology, including vesicle fusion, neurotransmitter release, 
and synaptic transmission, and also for muscle contraction (Hudman and 
Schulman, 2002). To achieve these events, a change in [Ca2+) is executed within 
the cells. Cells typically maintain relatively low intracellular [Ca2+) levels (10-7 M) 
compared with extracellular [Ca2+) levels (1 0-3 M) (Chin and Means, 2000). By 
increasing intracellular [Ca2+) levels from extracellular and intracellular Ca2+ 
storage (ER and mitochondria), the elevation of [Ca2+) level can trigger the 
Ca2+-mediated signaling pathways (Chin and Means, 2000). 
1.11.2 Inositol 3 phosphate (IP3)-mediated Calcium released signaling 
transduction pathway 
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As mentioned in the section 1.11.1, cells maintain a lower cytoplasmic [Ca2+] 
level and accomplish many physiological processes including neurotransmitter 
release and muscle contraction by elevating cytoplasmic [Ca2+] level, especially 
from intracellular Ca2+ storage (ER and mitochondria). One of the important 
signaling pathways to elevate intracellular [Ca2+] is the IP3-mediated Calcium 
release pathway. When GPCRs that are specific for mediating intracellular Ca2+ 
release receive outside signals, these active GPCRs activate downstream 
G-proteins. The active G-proteins stimulate Phospholipase C beta (PLCr3). Once 
PLCr3s are activated, PLCr3 will induce the hydrolysis of PIP2 to IP3 and DAG. 
Because IP3 is soluble, IP3 will diffuse and bind to the IP3R to trigger Ca2+ 
release from ER to the cytoplasm (Figure 1.11.1) (Berridge, 1993; Berridge et al., 
2000). 
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Figure 1.11.1. The PLC~/IP3R-mediated signaling is important in the regulation of 
Ca2+ release from ER. PLC~ can be activated by GPCR. The active PLC~ 
hydrolyzes PIP2 to IP3 and DAG. Furthermore, IP3 binds to IP3R and induces the 
channel opening of IP3R. The opened IP3R allows Ca2+ to release from ER to 
cytoplasm and increase the cytoplasmic Ca2+ concentration. 
1.11.3 The mechanism of CaMKII in regulating Calcium concentration 
CaMKII is a Ca2+/Calmodulin-dependent protein and a Ser/Thr protein kinase. 
CaMKII consists of three functional domains; a catalytic domain, a regulatory 
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domain, and an association domain (Figure 1.11.2) (Griffith, 2004; Kolb et al., 
1998; Shen and Meyer, 1998). CaMKII activity is regulated by 
autophosphorylation. CaMKII ordinarily exists as a multimeric structure within 
cells. When [Ca2+] is increased, Ca2+ and Calmodulin form an active Ca2+fCaM 
complex and then bind to the CaM-binding domain inside the regulatory domain of 
CaMKII. When this binding occurs, the active CaMKII subunit will phosphorylate 
the Threonine (Thr) 286 of the adjacent subunit, which switches on kinase activity. 
When all the Thr 286 in the subunits of CaMKII are phosphorylated and all active 
CaMs are trapped due to [Ca2+] increase, the dissociation rate of Ca2+fCaM 
increases more than 1000 fold (Griffith, 2004; Hudmon and Schulman, 2002). 
Next, the dissociation of Ca2+fCaMs from CaMKII subunits subsequently induce 
the phosphorylation on Thr 306 and Thr 307 of adjacent subunits. The 
phosphorylation of Thr 306/307 prevents CaMKII activities and also allows 
specific phospatases of CaMKII to remove the phosphate groups on 
Thr286/306/307 and inactivate CaMKII (Figure 1.11.2). The autophosphorylation 
of CaMKII can regulate CaMKII-mediated signaling efficiently and also maintain 
the Ca2+-related neuronal responses properly (Griffith, 2004; Hudmon and 
Schulman, 2002; Kemp et al., 1996; Lou and Schulman, 1989; Miller et al., 1988). 
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Figure 1.11.2. The autophosphorylation mechanism regulating CaMKII activity in 
Drosophila. When intracellular [Ca2+] increases, inactive CaMKII will bind to the 
Ca2+/CaM complex. This binding induces a conformational change in CaMKII and 
CaMKII trans-phosphorylates adjacent CaMKII on threonine 287 (T287). The 
CaMKII with T287 phosphorylation becomes Ca2+ independent and begins to 
release Ca2+/CaM complex; furthermore, CaMKII with T287 phosphorylation 
triggers autophosphorylation on threonine 306 and 307(T306/T307). This 
T287/T306/T307-capped CaMKII becomes Ca2+ insensitive and phosphatase 
which is CaMKII specific will dephosphorylate on T287, T306, and T307 and 
brings CaMKII back to inactive state. 
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1.11.4 The physiological role of CaMKII in nervous system 
CaMKII is one of the most abundant proteins in the nervous system. For 
example, CaMKII comprises up to 2% of total proteins in the mammalian 
hippocampus and 1% of total protein in the mammalian forebrain (Onodera et al., 
1990). Because of the high expression level of CaMKII in the forebrain and 
hippocampus and the alteration of CaMKII activity associated with long term 
potentiation (L TP) and long term depression (L TO), a long-lasting enhancement 
and reduction in signal transmission, respectively, this information implicates the 
importance of CaMKII in regulating forms of learning and memory (Bear and 
Malenka, 1994; Erondu and Kennedy, 1985; Hudmon and Schulman, 2002; 
Malenka and Bear, 2004; Riedel and Reymann, 1996). 
In Drosophila, it was previously found that motor neuron expression of 
CaMKf1T2BTD increased synapse number and decreased excitability in motor 
neurons (Park et al., 2002); both of these phenotypes are also exhibited in larvae 
expressing the constitutively active P/3K-CAAX(Howlett et al., 2008; Martin-Pena 
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et al., 2006). In conclusion, these results support the notion that levels of PI3K 
activity are specified, at least in part, by activity of CaMKII. 
1.12 Structure and function of Focal adhesion kinase 
1.12.1 The functional domains of Focal adhesion kinase 
Focal adhesion kinase (Fak) is a 125-kDa non-receptor tyrosine kinase which 
is expressed ubiquitously. Fak not only provides signalling and scaffolding 
functions at sites of integrin adhesion but is also involved in the regulation of 
integrin-mediated assembly and disassembly processes in cell-matrix attachment 
(Schlaepfer et al., 2004). Fak is composed of a protein 4.1, ezrin, radixin and 
moesin homology (FERM) domain, a kinase domain, proline-rich regions, and a 
focal adhesion targeting (FAT) domain (Figure 1.12.1 A) (Mclean et al., 2005; 
Schlaepfer et al., 2004). The functions of Fak domains will be discussed in two 
separate sections; 1) the domains involved in the association of integrins, and 2) 
the domains regulating Fak activation and catalytic activity. 
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Figure 1.12.1. Fak can activate PI3K and MAPK signaling cascades via Tyrosine 
kinase receptor, integrin, and GPCR-mediated singaling pathways. (A) Fak 
contains three functional domains, including a protein 4.1, ezrin, radixin and 
moesin homology (FERM) domain, a kinase domain, and a focal adhesion 
targeting (FAT) domain. (B) Fak can be activated by different types of upstream 
receptors, including integrins, tyrosine kinase receptors and GPCRs. These 
activations will induce Fak autophosphorylation on tyrosine 397, and the 
consequent conformational change activates Fak. Moreover, active Fak can 
activate PI3K or MAPK signaling cascades. 
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1.12.2 The integrin-association domains in Fak 
The FERM domain of Fak performs as a signalling linkage of receptor 
tyrosine kinases including integrins or growth factor receptors (Sieg et al., 2000). 
The FAT domain is located in the C-terminal region of Fak and consists of multiple 
motifs which mediates the association with integrin-associated proteins including 
paxillin and talin (Hildebrand et al., 1993; Schlaepfer et al., 2004). Because 
previous studies have shown that Fak cannot directly bind to integrins (Chen et al., 
1995), the integrin-associated proteins, such as Paxillin, serve as linkage for 
integrins to activate Fak (Schlaepfer et al., 1999; Schlaepfer and Hunter, 1997). In 
addition, two proline-rich regions in the C-terminal domain of Fak serve as binding 
sites for Src-homology 3 (SH3)-domain-containing proteins (Mitra et al., 2005). 
The lntegrin-mediated activation of Fak can regulate the cytoskeleton, cell 
adhesion and membrane morphogenesis to control cell movement (Mitra et al., 
2005). 
1.12.3 Regulation of FAK activation and catalytic activity 
36 
When Fak receives an input signal from cell surface-associated receptors 
such as integrins, G-protein couple receptors, and receptor protein tyrosine 
kinases, the autophosphorylaltion process will occur either in cis or trans to 
phosphorylate Tyr397 {Toutant et al., 2002). Tyr397 phosphorylation of Fak 
induces a conformational change in Fak and subsequently recruits Src homology 
2 (SH2)-containtig proteins, such as Src-family kinase (SFKs), p120 RasGAP, 
and the p85 subunit of phosphatidylinositol 3-kinase (PI3K) (Figure 1.12.1 B) 
(Hanks et al., 2003; Schlaepfer et al., 2004). This phosphorylation of Tyr397 is 
required for the activation of Fak. Once Src binds to Fak, Src phosphorylates Fak 
on Tyr576 and Tyr577 within the catalytic domain. The phosphorylation of Tyr576 
and Tyr577 increases the binding affinity between two Faks and induces the 
intermolecular phosphorylation of Tyr861 and Tyr925 on Fak (Figure 1.12.1 B) 
(Ruest et al., 2000; Schlaepfer et al., 2004). Moreover, Fak ,phosphorylated on 
Tyr861 and Tyr925 can become the docking site for SH2 domain adaptor proteins, 
such as Grb2 (an upstream signaling molecule of Ras and ERK), and induce the 
activation of multiple intracellular signaling cascades (Figure 1.12.1 B) (Schaller, 
2001; Schlaepfer et al., 1994; Schlaepfer et al., 1999; Schlaepfer and Hunter, 
1997). 
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1.12.4 CaMKII and FAK may both serve as molecular intermediates in the 
mGiuRIPI3K pathway to regulate neuronal excitability. 
Because of the variation of C-terminal domains within different metabotropic 
glutamate receptor (mGiuR) groups, each group activates different second 
messengers (Enz, 2007). For example, mammalian type I mGiuR evokes Ca2+ via 
small G protein (G a q)-mediated phospholipase C ~ (PLC ~) activation and 
IP3-dependent release of Ca2+ from intracellular stores. However, in Drosophila, 
there is only one mGiuR (which is DmGiuRA). Even though DmGiuRA is more 
similar to mammalian group II mGiuR, which inhibit adenylate cyclase, DmGiuRA 
may also play the roles of group I and Ill mGiuR since it is the sole mGiuR in 
Drosophila (Bogdanik et al., 2004). In addition, in 2002, the Griffith group 
published that neuronal overexpression of CaMKffT2B7D, which mimics CaMKII 
constitutive activation, resulted in failure of action potential propagation and 
increase in the number of boutons (Park et al., 2002). These results are similar to 
the phenotype of constitutive activation of PI3K (Howlett et al., 2008). In addition, 
Ueda et al. (2008) recently reported that the DFak null mutation DFakCG1 exhibits 
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neuronal hyperexcitability (Ueda et al., 2008), which might reflect inability to 
activate PI3K. Based on these researches, we believe Ca2+fCalmodulin-
dependent Kinase II (CaMKII) and Focal adhesion kinase (FAK), the substrate of 
CaMKII and activator of regulatory subunit of PI3K, may be the bridge between 
mGiuR and PI3K. Therefore, the roles of CaMKII and Fak in the mGiuR/PI3K 
signaling pathway need to be further characterized. 
1.13 The functions of the transcription factor Foxo 
Foxo proteins are composed of conserved DNA-binding domain (the 
Forkhead box, or FOX) and belong to the subgroup class '0' of the Forkhead 
family of transcription factors. Foxo has been shown to be regulated by the 
PI3K/AKT signaling pathway and regulates many physiological events including 
cell death, reactive oxygen species detoxification, DNA repair, cell cycle arrest, 
glucose metabolism, and energy homeostasis (Kops et al., 2002; Medema et al., 
2000; Nakae et al., 2001; Salih and Brunet, 2008). The mechanism by which Foxo 
controls life span is particularly well understood. In C. elegans, the Foxo homolog 
daf-16 is required to decrease insulin/PI3K/AKT signaling and promotes longevity 
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(Hsu et al., 2003; Libina et al., 2003; Murphy et al., 2003). Foxo is not only 
involved in the regulation of life span, but also in maintaining muscle function and 
neuronal excitability (Howlett et al., 2008). Recently, one study implicated Foxo 
and its target 4E-BP (a signaling molecule involved in protein synthesis) in 
preserving the function of proteostasis and delaying the decay of muscle function 
(Demontis and Perrimon). In addition, our data also implicated Foxo in the 
nervous system. In a Drosophila Foxo null mutant, the motor axon terminal 
showed a hypoexcitable phenotype (Howlett et al., 2008). This result suggested 
that Foxo is important in maintaining neuronal homeostasis and regulating 
neuronal excitability. Because Foxo is one of the downstream effectors of 
PI3K/AKT, Foxo also participates in the mGiuR/PI3K/AKT singling pathway to 
regulate neuronal excitability (Howlett et al., 2008). However, the target genes of 
Foxo in the regulation of neuronal excitability still remain unknown. 
1.14 The functions of translational repressor Pumilia 
The Pumilia (Pum) proteins are Puf domain-containing proteins and highly 
conserved in several organisms including yeast, Drosophila, Xenopus, plants, and 
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mammals (Spassov and Jurecic, 2003). Pum functions as a translational 
repressor. In Drosophila, previous studies have shown that Pum is essential in 
regulating several physiological events, including embryogenesis and neuronal 
function (Sonoda and Wharton, 1999; Wreden et al., 1997). During 
embryogenesis, Pum binds directly to specific sequences in the 3' untranslated 
region (UTR) of hunchback (hb) mRNA (known as nanos-response elements or 
NREs) (Sonoda and Wharton, 1999; Wreden et al., 1997) and then recruits at 
least two other proteins, Nanos (Nos) and Brain Tumor (Brat) (Murata and 
Wharton, 1995; Sonoda and Wharton, 1999; Sonoda and Wharton, 2001), by 
protein-protein interactions to inhibit the initiation of protein translation; this 
translational inhibition controls the posterior development of Drosophila embryos 
(Macdonald, 1992). 
In addition, Pum protein also plays an important role in the regulation of 
several neuronal events, such as neuronal excitability (Mee et al., 2004; Muraro et 
al., 2008; Schweers et al., 2002), dendrite morphogenesis (Ye et al., 2004), and 
postsynaptic protein translation (Menon et al., 2009; Menon et al., 2004; Salazar 
et al., 2010). For example, previous studies indicated that pum mutants exhibit 
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neuronal hyperexcitability (Schweers et al., 2002) and significantly elevated 
paralytic (Para; a Na+ channel) mRNA (Mee et al., 2004; Muraro et al., 2008). 
Therefore, these results suggested that Pum regulates neuronal excitability by 
acting as the translational repressor of para mRNA. In conclusion of section 1.11 
and 1.12, Foxo mutants exhibit neuronal hypoexcitability and pum mutants exhibit 
neuronal hyperexcitability. In addition, Pum is required in the regulation of the 
proper quantities of Para. Therefore, Foxo may regulate neuronal excitability by 
repressing transcription of pum and these indirectly control the translation of Para. 
1.15 Drosophila push and the ubiquitin-proteosome protein degradation system 
The ubiquitin-proteosome protein degradation system (UPS) is highly 
conserved from yeast to mammals. One of the major functions of UPS is a cellular 
quality control system that tags misfolded proteins by labeling them with multiple 
ubiquitins, a small protein with 76 amino acids, for refolding or degradation 
(Hershko and Ciechanover, 1998). Three major proteins catalyze this reaction 
sequentially: a ubiquitin activating enzyme (E1), a ubiquitin conjugating enzyme 
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(E2), and a ubiquitin ligase (E3) (Glickman and Ciechanover, 2002). Once the 
UPS system is triggered, the reactive site of ubiquitin is modified by E1 in a 
process requiring ATP as an energy source. Following the activation, ubiquitin is 
transferred from E 1 to the active site of E2 and then E2 binds to E3 and transfers 
the ubiquitin in two ways. One is a direct transfer of ubiquitin from E2 to the 
substrate protein, and the other one is via formation of the E3-ubiquitin 
intermediate followed by transfer of ubiquitin to the substrate protein (Figure 
1.15.1 ). After the substrate protein is tagged with a poly-ubiquitin chain, this 
protein can be rapidly degraded by the 26S-proteasome into small peptides 
(Figure 1.15.1) (Glickman and Ciechanover, 2002). The UPS system is also 
involved in regulating synapse development, presynaptic function, and 
neurotransmitter release (Yi and Ehlers, 2005). 
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Figure 1.15.1. The ubiquitin-proteasome (UPS) pathway. The activation of UPS 
begin with the transformation of ubiquitin from E1 to the active site of E2. Next, E2 
binds to target E3 and transfers the ubiquitin in two ways. One is a direct transfer 
of ubiquitin from E2 to the substrate protein. The other one is via formation of the 
E3-ubiquitin intermediate followed by transfer of ubiquitin to the substrate protein. 
Once the substrate protein is tagged with a poly-ubiquitin chain, this protein will be 
rapidly degraded by the 268-proteasome into small peptides and ubiquitin will be 
recycled. 
Drosophila Push is a large, -570 kD protein and is the suspected ortholog of 
the mammalian P600/UBR4 protein. Based on previous characterizations of Push 
and P600/UBR4, Push has been suggested to function as a Ca2+/Calmodulin-
binding protein (Porter et al., 1995; Yager et al., 2001), as an E3-ubiquitin ligase 
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(Tasaki et al., 2005), and as an ER binding protein (Shim et al., 2008) and 
therefore may participate in mar.y physiological events. P600/UBR4 belongs to 
the UBR family, a family of proteins involved in protein refolding and degradation 
(Tasaki et al., 2005), which are involved in membrane morphogenesis and in the 
prevention of anoikis, a type of programmed cell death that is induced by improper 
cell-matrix interaction (Nakatani et al., 2005). Drosophila Push has been 
implicated in the regulation of neurotransmitter release (Richards et al., 1996), 
chromatin scaffolding, male spermatogenesis (Richards et al., 1996), and 
perineurial glia growth (Yager et al., 2001). Even though push has been indicated 
in the regulation of many physiological events, the cellular locations and functional 
properties of push are totally unclear and needed more examination. 
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Chapter 2: CaMKII and DFak as critical intermediates in metabotropic 
glutamate receptor-mediated activation of PI3K 
2.1 Synopsis 
In Drosophila larval motor neurons, glutamate activation of the single mGiuR, 
called DmGiuRA, downregulates neuronal excitability (Bogdanik et al., 2004); 
glutamate both activates PI3K and requires PI3K activity for this downregulation 
(Howlett et al., 2008). Because glutamate is the excitatory neurotransmitter at the 
Drosophila neuromuscular junction (NMJ) (Jan and Jan, 1976), it was 
hypothesized that this DmGiuRA-mediated downregulation of neuronal excitability 
carried out a negative feedback on activity: glutamate released from motor nerve 
terminals would activate DmGiuRA autoreceptors, which would then depress 
excitability. 
Here we identify additional molecular components that mediate the activation 
of PI3K by DmGiuRA in Drosophila larval motor nerve terminals. We find that 
activity of the Calcium/calmodulin-dependent kinase II (CaMKII) is necessary for 
glutamate application to activate PI3K, and expression of the constitutively active 
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CaMKffT2BTD (Jin et al., 1998) is sufficient both to activate PI3K even in the 
absence of glutamate and to confer several other neuronal phenotypes consistent 
with PI3K hyperactivation. We also find that CaMKIJT2B7D requires the nonreceptor 
tyrosine kinase DFak for this PI3K activation: the DFaf<CGt null mutation (Grabbe 
et al., 2004) blocks the ability of glutamate application to activate PI3K, and 
prevents CaMKIJT2B7D from hyperactivating PI3K. Finally, CaMKffT2B7D expression 
completely suppresses the hyperexcitability conferred by the DmG/uRA null 
mutation DmG/uRAtt2b. We conclude that ligand activation of DmGiuRA activates 
PI3K via CaMKII and DFak. 
2.2 Materials and Methods 
2.2.1 Drosophila stocks 
For all experiments, Drosophila larvae were reared on standard cornmeal/ 
agar media at 22-23°. The D42Gal4 driver (Brand and Perrimon, 1993; Parkes et 
al., 1998), which expresses in motor neurons, was provided by Tom Schwarz 
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(Harvard Medical School, Boston, Massachusetts). Flies carrying the UAS-P/3J<DN 
(D954A) and UAS-P/3K-CMX transgenes (Leevers et al., 1996), encoding 
dominant-negative and constitutively active PI3K, respectively, were provided by 
Sally Leevers (London Research Institute, London, UK). Flies carrying the 
UAS-ala, UAS-CaMKffT2B7A and UAS-CaMKffT2B7D transgenes, which encode a 
CaMKII inhibitor peptide, calcium/calmodulin-dependent CaMKII, and 
calcium/calmodulin-independent CaMKII, respectively (Griffith et al., 1994; Park 
et al., 2002), were provided by Leslie C. Griffith (Brandeis University, Waltham, 
Massachusetts). Flies carrying the DFakCGt deletion mutation and UAS-DFak 
transgene (Grabbe et al., 2004) were provided by Ruth Palmer (Umea University, 
Umea, Sweden). Flies carrying the DmG/uRA tt2b deletion mutation (Bogdanik et 
al., 2004) were provided by Marie-Laure Parmentier (Unite Propre de Recherche 
Centre, Montpelier, France). All other fly stocks were provided by the Drosophila 
stock center (Bloomington, IN). 
2.2.2 Immunocytochemistry 
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Larvae were grown to the wandering third-instar stage in uncrowded 
half-pint bottles. Larvae were collected for experimentation only during the first 
and second days after the initial wandering third-instar larvae appeared. For basal 
phosphorylated Akt (p-Akt) measurements, larvae were dissected in Schneider's 
Drosophila media (Gibco) and fixed in Schneider's Drosophila media containing 
4% paraformaldehyde. For experiments involving glutamate application, larvae 
were dissected and then incubated for 1 minute in Schneider's Drosophila media 
containing 1 00 1-1M glutamate prior to the fixation procedure described above. 
Fixed larval tissues were incubated with a rabbit anti-Drosophila p-Akt (Ser505) 
polyclonal primary antibody (1 :500 dilution, Cell Signaling Technologies). The 
antibody used was from a different lot from the antibody used in a previous report 
(Howlett eta/., 2008) and thus might not have identical properties. Larvae were 
then incubated with Rhodamine Red conjugated goat anti-rabbit lgG (1 :500 
dilution, Jackson lmmunoResearch), and Cy-2 conjugated antibodies against 
horseradish peroxidase (1 :200 dilution, Jackson lmmunoResearch). 
lmmuno-labeled larval tissues in standard Phosphate Buffered saline (PBS, 0.128 
49 
M NaCI, 2.0 mM KCI, 4.0 mM MgCI2, 0.34 M sucrose, 5.0 mM HEPES, pH 7.1, 
and 0.15 mM CaCb) containing 50% glycerol were mounted onto slides. Care was 
taken to treat all samples identically during this procedure. Neuromuscular 
junctions (NMJs) from muscles 6 and 7 in segments A3, A4, A5 or A6 were 
imaged on a Zeiss LSM 510 confocal microscope system (Zeiss, Oberkochen, 
Germany) with a 20X objective. Optical sections were 10 IJm thick, which 
encompassed the entire NMJ. Optical parameters, including pinhole, gain, 
contrast, and brightness, were held constant for each experimental set. NMJs 
(marked by anti-HRP) were traced using the lmage-J (NIH, Bethesda, MD) 
freehand selection tool and the selection was transferred to the anti-p-Akt image 
where pixel intensity value was quantified. Background was obtained by 
averaging p-Akt intensity from muscles 6 and 7 from the same abdominal 
hemisegment, excluding the muscle nuclei and the neuromuscular junction. This 
background was then subtracted from the mean motor nerve terminal p-Akt pixel 
intensity. This p-Akt pixel intensity was then normalized to the mean p-Akt pixel 
intensity of wild type motor nerve terminals obtained in experiments performed in 
parallel. 
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To measure synaptic bouton number, larvae were grown, selected and 
dissected as described above, fixed in standard PBS containing 4% 
paraformaldehyde and labeled with Cy-2 conjugated antibodies against 
horseradish peroxidase (1 :200 dilution). Images were obtained as described 
above. The LSM Image Browser was used for quantifying bouton numbers and 
obtaining surface area of muscle 6 and 7 from abdominal segment A3 and A4. 
The number of boutons was counted manually. 
2.2.3 Transmission electron microscopy 
Transmission electron microscopy was performed as described previously 
(Howlett et al., 2008; Lavery et al., 2007). Briefly, larvae were grown, selected, 
and dissected as described above, fixed with glutaraldehyde and 
paraformaldehyde, stained with 0.5% Os04 and 2% uranyl acetate, and 
embedded in an eponate 12-araldite mixture. Ultrathin cross-sectional slices (pale 
gold, 120-nm-thick) were cut with an ultramicrotome, poststained with uranyl 
acetate and Reynolds lead citrate, and analyzed with a JEOL 1230 (JEOL Ltd., 
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Tokyo, Japan) transmission electron microscope at 80 kV. Carl Zeiss Axioversion 
software (Zeiss, Oberkochen, Germany) was used for analyzing axon diameter. 
Each experimental set was analyzed from the five largest axons (motor axons) 
from more than five different nerves from at least two different larvae. 
2.2.4 Electrophysiology 
Larvae were grown and selected as described above and dissected in 
Jan's buffer (128 mM NaCI, 2.0 mM KCI, 4.0 mM MgCI2, 34 mM sucrose, 4.8 mM 
HEPES, pH 7.1, and CaCI2 concentration as specified in the text). Peripheral 
nerves were cut immediately posterior to their exit from the ventral ganglion, and 
were stimulated with a suction electrode at a 5V stimulus intensity. Muscle 
recordings were taken from muscle 6 in abdominal sections 3-5. Stimulus 
duration, approximately 0.05 msec, was adjusted to 1.5 times threshold which 
reproducibly stimulates both axons innervating muscle 6. Intracellular recording 
electrodes for muscle potentials were pulled with a Flaming/Brown micropipette 
puller to a tip resistance of 10--40 MQ and filled with 3M KCI. Rate of onset of long 
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term facilitation (L TF) and excitatory junction potential (EJP) amplitude are 
reported as geometric means because the data show a positive skew. For all 
long-term facilitation (L TF) experiments, the bath solution contained 0.15 mM 
[Ca2+) and 100 ~M quinidine, which is a potassium channel blocker that sensitizes 
the motor neuron and enables L TF to occur and measured even in hypoexcitable 
neurons. 
2.3 Results 
2.3.1 CaMKII regulates P13K activity in Drosophila motor nerve terminal 
Metabotropic glutamate receptors (mGiuRs) are G-protein-coupled 
receptors for which glutamate is ligand. In Drosophila, the DmG/uRA tt2b null 
mutation in the single mGiuR increases motor neuron excitability by preventing 
activation of the lipid kinase PI3K (Bogdanik et al., 2004; Howlett et al., 2008). 
Given that glutamate is the major excitatory neurotransmitter at neuromuscular 
junctions (NMJs) in insects such as Drosophila (Jan and Jan, 1976), it was 
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suggested that DmGiuRA in motor neurons participates in a negative feedback: 
glutamate released from motor nerve terminals as a consequence of neuronal 
activity activates DmGiuRA autoreceptors in motor nerve terminals. DmGiuRA 
activation downregulates subsequent neuronal activity by activating PI3K. In this 
view, DmG/uRA tt2b increases excitability by preventing PI3K activation and thus 
severing this negative feedback. This view is supported by the observation that 
transgene-induced PI3K inhibition increases neuronal excitability in a manner 
similar to DmG/uRAt12b, whereas transgene-induced PI3K activation decreases 
neuronal excitability (Howlett et al., 2008). However, the molecular mechanism by 
which glutamate-DmGiuRA activates PI3K was not elucidated. 
We initially hypothesized that the Calcium/calmodulin-dependent kinase II 
(CaMKII) might be an essential intermediate in DmGiuRA-mediated PI3K 
activation. Although the possibility that CaMKII can activate PI3K has only 
recently been reported (Ma et al., 2009), altered CaMKII activity alters certain 
motor neuron phenotypes in Drosophila in a manner similar to altered PI3K 
activity (Griffith et al., 1994; Park et al., 2002). One way that CaMKII activity can 
be altered is by expression of the constitutively active CaMKffT2B7D: this variant is 
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rendered active even in the absence of calcium or calmodulin by the 
phosphomimetic T287D substitution in the autophosphorylation site (Fong et al., 
1989). It was previously found that motor neuron expression of CaMKI!T2B7D 
increased synapse number and decreased excitability in motor neurons (Park et 
al., 2002); both of these phenotypes are also exhibited in larvae expressing the 
constitutively active P/3K-CMX (Howlett et al., 2008; Martin-Pena et al., 2006). 
Similarly, CaMKII inhibition accomplished by transgenic expression of the CaMKII 
inhibitory peptide "ala" (Joiner Ml and Griffith, 1997) increases motor neuron 
excitability and decreases synapse number (Park et al., 2002); both of these 
phenotypes are also exhibited in transgenic larvae in which PI3K activity is 
blocked. Taken together, these results support the notion that levels of PI3K 
activity are specified, at least in part, by activity of CaMKII. 
To test the prediction that altered CaMKII activity would alter PI3K activity 
in Drosophila larval motor nerve terminals, we used the D42 motor neuron Ga/4 
driver to express transgenes encoding either the nonactivated CaMKffT2B7A (which 
acts equivalently to wildtype in all assays performed to date), the 
constitutively-active CaMKI/T2B7D or the CaMKII inhibitory peptide ala in motor 
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neurons, and then evaluated effects of these transgenes on PI3K activity. We 
monitored PI3K activity with an antibody against the phosphorylated form of the 
kinase Akt (p-Akt), which increases upon PI3K activation and is a well-established 
readout for PI3K activity (Colombani et al., 2005; Dionne et al., 2006; Palomero et 
al., 2007). We found that expressing the activated CaMKffT2BTD, but not the 
non-phosphorylatable CaMK/fT2B7A, increased p-Akt levels in motor nerve 
terminals about 40% (Figure 2.3.1, p=0.002, n=29), which is similar to, but less 
extreme, than the two-fold increase in p-Akt conferred by transgene-induced PI3K 
activation (Howlett et al., 2008). The magnitude of this response is similar to the 
magnitude of the p-Akt increase induced during mGiuR-mediated LTD in the 
mouse hippocampus (Hou and Klann, 2004 ), consistent with the possibility that 
the p-Akt increases in the Drosophila and mammalian systems occur via a 
common pathway. 
The previous study in which this approach was used (Howlett et al., 2008) 
was not able to distinguish possible differences in basal p-Akt levels among 
genotypes because of high sample errors. However, by significantly increasing 
sample size and by including data normalization to accommodate signal 
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variability, we were able to show that CaMKII inhibition via ala expression 
decreased basal p-Akt about 25% (Figure 2.3.1, p=0.033, n=16). These results 
support the notion that CaMKII activity specifies PI3K activity in larval motor 
neurons. 
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Figure 2.3.1: CaMKII activity increases levels of p-Aid in larval motor nerve 
terminals in a DFak-dependent manner. (A) Representative confocal images of 
third instar larval neuromuscular junctions of wildtype ( W7), D42>CaMKffT2B7D and 
DFaf<CG1 stained with anti-pAkt (upper panels), anti-HRP (center panels) , and 
merged images (lower panels). All images are taken from muscles 7 and 6 from 
abdominal segment A3, A4, A5 or A6. Scale bar is 20 J.Jm. (B) Mean normali~ed 
p-Akt intensity (Y axis) +/- SEM for the following genotypes (X axis): D42>+, 
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DFaf<CG1, D42>CaMKffT287D, D42>CaMKffT287A, D42>ala, DFaf<CGt; D42>DFa~, 
DFaf<CGt; D42>CaMKffT287D and D42>CaMKffT287D, P/3J<DN. Anti-HRP was applied 
to outline nerve terminals. Pixel intensities were quantified using lmageJ software 
and background subtraction was performed as described in the Methods section. 
The normalized p-Akt intensities are shown as a ratio change compared to wild 
type. From left to right, n = 65, 70, 29, 30, 16, 84, 35, 18 respectively, for each 
genotype. One-way ANOVA and Fisher's LSD were performed for statistical 
analysis and gave the following differences: For D42>+; vs. DFaf<CG1, p=0.008; vs. 
D42>CaMKffT2B7D, p=0.002; vs. D42>CaMKffT2B7A, p=0.62; vs. D42>ala, p=0.033; 
vs. DFaf<CGt; D42>DFak+, p=0.34. For DFaf<CGt; vs. DFaf<CGt; D42>DFa~. 
p=0.018; vs. DFaf<CGt; D42>CaMK/IT2B7D, p=0.40. For D42>CaMK/fT2B7D; vs. 
DFaf<CGt; D42>CaMKffT287D, p<0.001; vs. D42>CaMKffT287D, P/3J<DN, p=0.001. P 
values <0.05 were considered statistically significant. 
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2.3.2 Focal Adhesion Kinase (DFak) is required for CaMKII to activate PI3K 
Next we wanted to identify molecules that might serve as intermediates 
linking activated CaMKII with PI3K activation. We hypothesized that the 
nonreceptor tyrosine kinase Focal Adhesion Kinase (DFak) might play such a 
role: DFak is the single Drosophila orthologue of the family which in mammals 
consists of both Fak and the closely related Pyk2. In mammals, CaMKII 
phosphorylates Pyk2 on multiple serine residues on the C terminus, which leads 
to Pyk2 tyrosine phosphorylation and activation by mechanisms that are 
incompletely understood (Della Rocca et al., 1997; Fan et al., 2005; Heidinger et 
al., 2002; Montiel et al., 2007; Soltoff, 1998; Zwick et al., 1999). CaMKII also 
phosphorylates mammalian Fak on C terminal serine residues, although the 
functional significance of these phosphorylations remain unknown (Fan et al., 
2005). Furthermore, both Pyk2 and Fak are capable of activating PI3K (Avraham 
et al., 2000; Chen et al., 1996; Chen and Guan, 1994; Dikic et al., 1996; 
Guinebault et al., 1995; Montiel et al., 2007; Rocic et al., 2001; Schlaepfer et al., 
1994). Two CaMKII phosphorylation sites on Fak, serines 843 and 910, are 
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conserved in DFak (Figure 2.3.2), raising the possibility that CaMKII 
phosphorylates DFak at these serine positions, which leads to DFak, and then 
PI3K, activation (Grabbe et al., 2004). 
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Figure 2.3.2: Two CaMKII phosphorylation sites on DFak are conserved. Portion 
of Focal adhesion kinase alignmemt among different animal speices was 
analyzed by Clustalw. Asterisks indicate two conserved serine. 
If DFak acts downstream of CaMKII, then the DFak null mutation DFaf<CG1 is 
predicted to decrease motor nerve terminal PI3K activation, and prevent 
CaMKIIT287D_dependent PI3K activation. As shown in Figure 2.3.1, PI3K activity in 
motor nerve terminals, as monitored by levels of p-Akt, was decreased in DFaf<CG1 
to 80°/o of wildtype (p=0.008, n=70). Furthermore, this decrease was rescued by 
motor neuron expression of a DFak+ transgene (Figure 2.3.1 ), demonstrating that 
this effect of DFaf<CGt resulted from loss of DFak specifically within motor neurons. 
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Furthermore, DFaf<CGt larvae expressing CaMKIIT287D in motor neurons did not 
exhibit the increased p-Akt levels in motor nerve terminals observed when 
CaMKIIT287D was expressed in an otherwise wildtype background (Figure 2.3.1, 
p<0.001). Rather, p-Akt levels were decreased to levels similar to those observed 
in DFaf<CG1 larvae in the absence of CaMKIJT287D expression (p=0.4). Similarly, 
co-expression with the dominant-negative PIJJ<DN (Leevers et al., 1996) blocked 
the ability of CaMKffT2B7D to increase p-Akt levels (Figure 2.3.1 ). Taken together, 
these results confirm that both DFak and PI3K activities are required for CaMKII 
to increase p-Akt levels. 
2.3.3 CaMKII and DFak are required for PI3K activation by glutamate application 
It was previously demonstrated that application of glutamate to larval NMJs 
in filleted third instar larval preparations activates PI3K, as monitored by 
glutamate-induced increases in p-Akt levels in motor nerve terminals (Howlett et 
al., 2008). Furthermore, these glutamate-evoked p-Akt increases were blocked by 
the null mutation DmG/uRAtt2b, or by presynaptic inhibition of either DmGiuRA or 
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PI3K (Howlett et al., 2008), which demonstrated that glutamate activated PI3K via 
DmGiuRA autoreceptors. If CaMKII and DFak are critical intermediates in 
glutamate/DmGiuRA-induced PI3K activation, then inhibition of either molecule is 
predicted to block this glutamate-induced PI3K activation. To test this possibility, 
we applied 0.1 mM glutamate to DFaJ<CGt larvae, or to larvae expressing the 
CamKII inhibitory peptide ala in motor neurons. We found that wildtype larvae 
showed a robust glutamate-induced PI3K activation, as monitored by 
immunocytochemistry against p-Akt (Figure 2.3.3, p=0.001 ), following 1 minute of 
glutamate application. This percent increase is similar to the increase reported 
during mGiuR-mediated LTD in the mouse hippocampus (Hou and Klann, 2004) 
in which a 5 minute application of a glutamate analog evoked about a 50% 
increase in p-Akt levels. In contrast, blocking either CaMKII or DFak blocked this 
increase (Figure 2.3.3, p=0.64 and p=O. 77, respectively). Furthermore, the motor 
neuron expression of UAS-DFaf<+ restored normal glutamate sensitivity to 
DFaJ<CGt (Figure 2.3.3). 
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Figure 2.3.3: The glutamate-evoked increase in presynaptic p-Akt levels requires 
CaMKII and DFak. (A) Representative confocal images of third instar larval 
neuromuscular junctions of wildtype (WT or +/+), DFaf<CG1 and DFaf<CGt; 
D42>UAS-DFaf<+ either prior to (-) or 1 min following ( +) application of 100 1-JM 
glutamate. Larvae were stained with anti-p-Akt (left panel) and anti-HRP (right 
panel). All images are from muscles 7 and 6 of abdominal segment A3, A4, A5 or 
A6. Scale bar is 20 1-Jm. (B) Mean normalized p-Akt intensity (Y axis) +/- SEM, 
both prior to and following 1 min glutamate application, for the following 
genotypes (X axis): D42>+, DFaf<CGt, D42>a/a, and DFaf<CG1; D42>DFaf<+. 
Anti-HRP was applied to outline nerve terminals. Pixel intensities were quantified 
using lmageJ software and background subtraction was performed as described 
in the Methods section. The normalized p-Akt intensities are shown as a ratio 
change compared to wild type. From left to right, n = 65, 56, 70, 48, 84, 24, 32, 36, 
respectively, for each genotype. One-way ANOVA and Fisher's LSD were 
performed for statistical analysis. P values <0.05 were considered statistically 
significant. 
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2.3.4 CaMKII promotes synapse formation via DFak-dependent PI3K activation 
CaMKII activity was previously shown to promote arborization and increase 
synapse number at the larval NMJ (Park et al., 2002) by phosphorylating 
discs-large and thus decreasing levels of Fas2 (Koh et al., 1999). The observation 
that CaMKII acts downstream of integrins for this control of synapse structure 
(Beumer et al., 2002) is consistent with a role for DFak in this process as well. In 
addition, arborization and synapse number are regulated by PI3K activity: 
activating PI3K by expressing the constitutively-active P/3K-CAAX increases 
synapse number about 2.5-fold, whereas blocking PI3K by expressing the 
dominant-negative P/3J<DN decreases synapse number about two-fold (Howlett et 
al., 2008; Martin-Pena et al., 2006). From these data and the results shown 
above, we hypothesized that CaMKII promotes synapse formation at least in part 
by activating PI3K in a DFak-dependent manner. We confirmed the previous 
findings of Park et al. (Park et al., 2002), that expressing CaMKffT2B70, but not 
CaMKffT2B7A, in motor neurons increased bouton number about 30% (Figure 2.3.4, 
p=0.001 ), an increase similar to, though less extreme, than the increase conferred 
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by P/3K-CMX. We found that this CaMKffT2B7D_dependent increase required 
PI3K activity: in larvae co-expressing Pf31(DN and CaMKffT2B7D, the 
CaMKffT2B7D-dependent increase in bouton number was completely suppressed, 
and in fact was decreased to a value indistinguishable from that conferred by 
P/3/(DN alone (Figure 2.3.4). 
To determine if DFak is a required intermediate in this CaMKII-dependent 
P13K activation, we measured synapse number in DFaf<CGt larvae both in the 
presence and absence of CaMKffT2B7D expression. We found that in the absence 
of CaMK1fT2B7D expression, synapse number in DFaf<CGt larvae was highly 
variable and therefore differences with wildtype failed to reach statistical 
significance (p=0.051 ). However, there was a tendency for DFaf<CGt synapse 
number to decrease, rather than increase, compared to wildtype (Figure 2.3.4). 
Thus we were unable to confirm the finding of Tsai et al. (2008), who reported that 
DFak inhibition increases synapse number at the larval NMJ. However, DFaf<CGt 
completely suppressed the increased synapse number conferred by CaMKffT2B7D 
expression (Figure 2.3.4, p=0.001 ); synapse number in DFaf<CGt larvae 
expressing CaMKffT2B7D was indistinguishable from synapse number in DFaf<CGt 
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alone (Figure 2.3.4, p=0.89). These data support the notion that CaMKII 
activates PI3K in a DFak-dependent manner. 
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Figure 2.3.4: The increase in motor neuron synapse number conferred by 
CaMKIIT287D expression requires DFak and PI3K. (A) Representative confocal 
images of third instar larval neuromuscular junctions of D42>+, D42>CaMK1fT2B7D, 
DFaf<CG1, D42>CaMK1fT287D, P/Jf<DN, DFaf<CG1,· D42>DFak+, and DFaf<CG1; 
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D42>CaMKI/T2B7D. Nerve terminals were visualized by staining with anti-HRP. 
Scale bar is 20 IJm. (8) Means +/- SEMs of synaptic bouton number normalized to 
the total surface area of muscle (Y axis) for the following genotypes (X axis): 
042>+, D42>CaMK//T2B7A, D42>CaMKftT2B7D, D42>P/3f<DN, D42>PI3f<DN, 
CaMKI!T287D, DFaf<CG1,DFaf<CGt; D42>DFak+, and DFaf<CGt; D42>CaMKffT2B70. All 
measurements were performed on nerve terminals on muscles 6 and 7 from 
abdominal segment A3. From left to right, n = 25, 12, 18, 8, 16, 26, 28, 17, 
respectively, for each genotype. The white arrow indicates one single bouton. 
One-way ANOVA and Fisher's LSD were performed for statistical analysis. 
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We also found that blocking CaMKII in motor neurons by expressing the 
CaMKII-inhibitor peptide ala decreased synapse number about two-fold (Figure 
2.3.5, p<0.001 ). If this decrease were a consequence of failure to activate PI3K, 
then expression of the constitutively active (and hence CaMKII-independent) 
P/3K-CAAXwould be predicted to suppress these effects of CaMKII inhibition. We 
confirmed this prediction: the a/a-dependent decrease in synapse number was 
completely suppressed by co-expression with P/3K-CMX: synapse number in 
larvae expressing both ala and P/3K-CAAXwas significantly increased compared 
to synapse number in larvae expressing ala alone (Figure 2.3.5, p<0.001 ), and 
was indistinguishable from synapse number in larvae expressing P/3K-CAAX 
alone (Figure 2.3.5, p=0.53). In addition, we found that synapse number in larvae 
expressing P/3K-CAAX was similarly unaffected by the presence of DFaJ<CGt 
(Figure 2.3.5). Taken together, these results suggest that CaMKII increases 
synapse number by the DFak-dependent activation of PI3K. 
Certain genotypes exhibited altered bouton morphology in addition to altered 
bouton number. For example, boutons in DFaJ<CG1 mutants often appear to be 
larger in size than wildtype. The DmGiuRA t12b mutation was similarly found to 
70 
increase bouton size (Bodganik eta/., 2004). These observations are consistent 
with the possibility that DFak activation is attenuated in the absence of DmG/uRA. 
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Figure 2.3.5: Constitutive PI3K activation suppresses the decrease in synapse 
number conferred by CaMKII or DFak inhibition. (A) Representative confocal 
images of third in star larval neuromuscular junctions of 042>+, D42>ala, D42>ala, 
P/3K-CAAXand DFaf<CGt,· D42>P/3K-CMX Nerve terminals were visualized by 
staining with anti-HRP. Scale bar is 20 ~m. (B) Means +/- SEMs of synaptic 
bouton number normalized to the total surface area of muscle (Y axis) for the 
following genotypes (X axis): 042>+, 042>ala, D42>PI3K-CAAX, 042> ala, 
P/3K-CAAX, and DFaf<CG1,· D42>P/3K-CMX All measurements were performed 
on nerve terminals on muscles 6 and 7 from abdominal segment A3. From left to 
right, n = 25, 12, 15, 8, 10, respectively, for each genotype. One-way ANOVA and 
Fisher's LSD were performed for statistical analysis. 
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2.3.5 CaMKII activity increases motor axon diameter by the DFak-dependent 
activation of P13K 
Larval motor axon diameter is specified by the level of PI3K activity: 
expressing constitutively active P/3K-CAAXincreases motor axon diameter about 
75% (0.8 1-1m to 1.4 tJm), whereas expressing the dominant-negative P/3J<DN 
decreases motor axon diameter (Howlett et al., 2008). To determine if CaMKII 
similarly regulates motor axon diameter, we expressed CaMKffT2B7D in motor 
axons and found as predicted significantly increased (about 40%) motor axon 
diameters (Figure 2.3.6, p=0.001 ), an increase similar to, but less extreme than, 
the increase conferred P/3K-CAAX. In addition, the CaMKffT2B7D_dependent 
increase, but not the P/3K-CAAX-dependent increase, in axon diameter was 
blocked by DFaf<CGt (Figure 2.3.6, p=0.004). Taken together, these results 
suggest that CaMKII increases motor axon diameter by the DFak-dependent 
activation of PI3K. 
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Figure 2.3.6: DFak is required for the increased motor axon diameter conferred by 
CaMKII, but not PI3K. (A) Representative transmission electron micrographs of 
cross sections of peripheral nerves from 042>+ and 042>CaMKI/T2B7D larvae. The 
-80 motor and sensory axons within the nerve are surrounded by at least two 
layers of glia. Diameter of the motor axons, the largest axons in the nerve, are 
considerably increased in 042>CaMK!IT2B7D. An axon is marked with an arrow. 
Scale bar is 2 lJm. (B) Mean axon diameter +/- SEMs of the five largest axons 
(which are motor axons) from each nerve (Y axis) for the following genotypes (X 
axis): 042>+, 042>CaMK!IT287D, OFaf<CGt, OFaf<CGt,· 042>CaMKI/T287D, DFaf<CGt; 
042>0Fak+, and OFaf<CGt,· 042>P/3K-CAAX. Nerves from at least two different 
larvae were scored for these axon measures. From left to right, n = 6, 7, 5, 5, 7, 5, 
nerves respectively, for each genotype. One-way ANOVA and Fisher's LSD were 
performed for statistical analysis. 
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2.3.6 Altered CaMKII and DFak activities alter motor neuron excitability 
PI3K activity regulates motor neuron excitability: transgene-induced PI3K 
activation decreases neuronal excitability, whereas transgene-induced PI3K 
inhibition increases neuronal excitability (Howlett et al., 2008). Additional reports 
have demonstrated that CaMKII and DFak also regulate Drosophila neuronal 
excitability (Griffith et al., 1994; Park et al., 2002; Ueda et al., 2008), raising the 
possibility that CaMKII, DFak and PI3K might regulate excitability via a common 
pathway. However, in each previous report, different sets of excitability assays 
were used, which complicates attempts to assign the effects of these three genes 
to specific pathways. 
To address this complication, we monitored motor neuron excitability in 
DFaf<CGt and in larvae expressing the constitutively active CaMKffT2B7D with the 
same assay previously employed to monitor excitability in larvae with altered PI3K 
activity. With this assay, the larval neuromuscular preparation (Jan and Jan, 
1976), transmitter release from motor neurons is evoked by nerve stimulation, and 
the amount of transmitter released is inferred from the amplitude of the muscle 
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depolarization (termed the excitatory junction potential, or EJP). Using this assay, 
we employed the same readouts to evaluate neuronal excitability in DFa/(CGt 
larvae, and in larvae expressing CaMKffT2B7D, that were previously employed for 
altered PI3K (Howlett et al., 2008). 
First, we measured rate of onset of a phenomenon termed "long term 
facilitation" (L TF) (Jan and Jan, 1978). LTF is a form of synaptic plasticity induced 
when a larval motor neuron is subjected to a train of repetitive nerve stimulations 
at low external [Ca2+]. At a certain point during the stimulus train, a threshold is 
reached, and subsequent stimulations elicit EJPs greatly increased in amplitude 
and duration. This long term facilitation results from increased and asynchronous 
neurotransmitter release, which in turn results from increased duration of nerve 
terminal depolarization (Jan and Jan, 1978). The number of stimulations required 
to reach this L TF threshold (L TF onset rate) is decreased by increased neuronal 
excitability (Jan and Jan, 1978; Mallart et al., 1991; Poulain et al., 1994; Schweers 
et al., 2002; Stern and Ganetzky, 1989; Stern et al., 1990). Both the DmG/uRA 112b 
null mutation and transgene-induced inhibition of P/3K greatly decrease the 
number of nerve stimulations required to reach L TF and thus greatly increase L TF 
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onset rate (Bogdanik et al., 2004; Howlett et al., 2008). This increased L TF 
onset rate indicates increased excitability in these genotypes. The possibility that 
DFak is required for DmGiuRA-dependent PI3K activation predicted that DFaf<CGt 
would prevent this PI3K activation and similarly increase the L TF onset rate. This 
prediction was confirmed (Figure 2.3.7). This increased L TF onset rate was 
rescued by motor neuron-dependent expression DFak+, confirming that DFak is 
required in the motor neuron for this effect. In contrast, the possibility that 
CaMKIIT287D constitutively activates PI3K would predict that CaMKffT2B7D 
expression would decrease L TF onset rate, which we also confirmed (Figure 
2.3.7). 
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Figure 2.3.7: CaMKII and DFak regulate motor neuron excitability. The larval 
neuromuscular preparation (Jan and Jan, 1976) was used for all recordings. Left 
panel: representative traces showing increased rate of onset of L TF in DFaf<CGt, 
and decreased rate of onset of L TF in larvae overexpressing CaMKIIT287D in motor 
neurons. Arrowheads indicate the increased and asynchronous EJPs, indicative 
of onset of LTF. The bath solution contained 0.15 mM [Ca2+] and 100 J,JM 
quinidine. Right panel: Geometric means +/- SEMs of the number of stimulations 
required to evoke L TF (Y axis) at the indicated stimulus frequencies (X axis) for 
the following genotypes 042>+, DFaf<CGt, D42>CaMKffT2B7D, and DFaf<CGt; 
D42>DFaf<+. From top to bottom, n = 7, 8, 18, and 6, respectively, for each 
genotype. One-way ANOVA and Fisher's LSD gave the following differences, at 
10Hz, 7Hz, 5Hz and 3Hz, respectively: for D42>+vs. DFaf<CGt, p=0.028, 0.022, 
0.016, 0.127; vs. D42>CaMKffT287D, p=0.001, 0.006, 0.007, 0.011; vs. DFaf<CGt; 
D42>DFaf<+, p=0.503, 0.876, 0.859, 0.327. P values <0.05 were considered 
statistically significant. 
Second, we measured EJP amplitude evoked by single nerve stimulations 
at low external [Ca2+]. At these low [Ca2+], Ca2+ is limiting for transmitter release, 
and mutations that alter excitability, and hence Ca2+ influx, have significant effects 
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on EJP amplitude (Ganetzky and Wu, 1982; Huang and Stern, 2002). In 
particular, transgene-induced PI3K activation decreases EJP amplitude, whereas 
transgene-induced PI3K inhibition increases EJP amplitude (Howlett et al., 2008). 
The possibility that DFak is required for DmGiuRA-dependent PI3K activation 
predicted that DFaf<CGt would prevent this PI3K activation and similarly increase 
EJP amplitude. We found that DFaf<CGt significantly increased EJP amplitude at 
0.15 mM and 0.2 mM [Ca2+) (Figure 2.3.8), but was not significantly different from 
wildtype at 0.1 mM [Ca2+), at which transmitter release is the smallest and errors 
are the greatest. This increased EJP amplitude was rescued by motor 
neuron-dependent expression DFaf<+, confirming that DFak is required in the 
motor neuron for this effect. 
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Figure 2.3.8: CaMKII and DFak regulate motor neuron excitability. Left panel: 
representative traces showing the increased excitatory junction potential (EJP) 
amplitude in DFaf<CGt larvae, and the decreased EJP amplitude in larvae 
overexpressing CaMKIIT287D in motor neurons, at a bath (Ca2+] of 0.15 mM. Right 
panel: mean EJP amplitudes +/- SEMs (Y axis) at the indicated [Ca2+] (X axis), 
from the following genotypes: 042>+, DFaf<CGt, D42>CaMKffT2B7o, and DFaf<CGt,· 
D42>DFa/<l". Larval nerves were stimulated at a frequency of 1 Hz, and 10 
responses were measured and averaged from each nerve. n = (6, 6, 6), (14, 8, 9), 
(6, 6, 6), and (10, 6, 6), respectively, for each genotype and [Ca2+] (0.2 mM, 0.15 
mM, 0.1 mM). One-way ANOVA and Fisher's LSD gave the following differences 
at 0.2 mM, 0.15 mM and 0.1 mM (Ca2+], respectively: for 042>+ vs. DFaf<CGt, 
p=0.021, 0.012, 0.21; vs. D42>CaMKffT287D, p=0.001, 0.005, 0.484; vs. DFaf<CGt; 
D42>DFa/<l", p=0.375, 0.941, 0.040. P values <0.05 were considered statistically 
significant. 
To confirm that these effects on EJP amplitude reflected altered transmitter 
release rather than altered responsiveness of the muscle to transmitter, we 
compared the amplitude of miniature EJPs (mEJPs), which reflect the 
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spontaneous release of individual vesicles of neurotransmitter, in wildtype larvae 
vs. DFaf<CG1 larvae and DFaf<CG1 larvae expressing DFaf<+ in motor neurons 
(Figure 2.3.9). We found that mEJP amplitude was unaffected in these three 
genotypes. Thus the increased EJP amplitude observed in DFaf<CG1 reflects 
increased neurotransmitter release. 
The possibility that CaMKI/T2BTD constitutively activates PI3K would predict 
that CaMKffT2B7D expression would decrease EJP amplitude. We found that as 
predicted, CaMKffT2BTD expression decreases EJP amplitude at each [Ca2+] tested 
(Figure 2.3.8) while having no significant effect on mEJP amplitude (Figure 2.3.9). 
This observation supports the conclusion that decreased neurotransmitter release 
underlies the decreased EJP amplitude conferred by CaMKffT2B7D. 
81 
042 > + 
* 
"' ~ ;, . i\. ~-... i ...._,.,--..(..,..__ ~\,~ ............ ;'.....,___ 
t tt t t t t . t t 
* 
* t ~(\._,.....,.......__-....,... _.-......,..\.~...J\ .... _ _, ...... }.,._.._J ...... 
t t ; tt ttt : tttt 
042 > CaMK1fi 2870 
* -~·!··-~"'~~-.~ -""-"'"............,._....;;'......__ .. ~ 
t 1t t · tt 1 t t tt t r r tt 
* 
-+--<"'-':1*._1~ .-r---...-J"IV. "-•'--
tt t 
1 
t tt t n t 
~mv 
200 msec 
> ~ 0.8 
Q) 
"'0 
:E 0.6 
Q. 
E 
t'l3 0.4 
0.. 
...., 
~ 0.2 
0 
Figure 2.3.9: The mEJPs are not affected in 042 > +, OFaJcCGt, 042 > CaMKJfT2B7D, 
and OFaJcCGt, 042 > DFak'". Left panel: representative traces showing mini EJPs 
(mEJP, marked by arrows) in 042>+, DFaf<CGt, D42>CaMKf1T2B7D, and OFaf<CGt; 
D42>0Faf<+. Two traces from each genotype are from two different larvae. The 
asterisks indicate EJPs evoked by single stimulations. Right panel: Mean mEJP 
amplitudes +/- SEMs (Y axis) for the indicated genotypes (X axis): 042>+, 
DFaf<CG1, D42>CaMKf1T2B7D, and DFaf<CGt,· 042>0Faf<+. Recordings were 
collected from five different larvae from each genotype in a bath [Ca2+] of 0.15 mM, 
and 30 responses were measured and averaged from each larva. One-way 
AN OVA and Fisher's LSD gave the following differences; For 042>+ vs. 0Faf<CG1, 
p=0.127; vs. D42>CaMKf1T2B7D, p=0.265; vs. DFaf<CG1,· 042>0Faf<+, p=0.354. For 
0Faf<CG1 vs. D42>CaMKfiT287D, p=O. 788; vs. DFaf<CG1,· 042>0Faf<+, p=0.332. For 
D42>CaMKfiT2B7D vs. DFaf<CGt,· D42>DFaf<+, p=0.572. P values <0.05 were 
considered statistically significant. 
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2.3. 7 Activating CaMKII prevents hyperexcitability of the DmGiuRA 112b null 
mutant 
The DmG/uRA112b null mutant exhibits extreme neuronal hyperexcitability, as 
shown by a greatly increased rate of onset of L TF (Bogdanik et al., 2004; Howlett 
et al., 2008). This hyperexcitability is completely suppressed by expression of the 
constitutively active P/3K-CMX and thus reflects failure to activate PI3K (Howlett 
et al., 2008). If this failure to activate PI3K is a consequence of failure to activate 
CaMKII, then this hyperexcitability is predicted to be suppressed by 
transgene-induced expression of the constitutively active CaMKJJT2B7D. To test this 
prediction, we compared rate of onset of LTF in DmG/uRA112b mutants and in 
DmG/uRA 112b mutants expressing CaMKJJT2B7D in motor neurons. We found that 
CaMKJJT2B7D expression completely suppressed the hyperexcitability of 
DmG/uRA 112b, and decreased excitability to a level indistinguishable from the 
hypoexcitabiliy in larvae in which CaMKJJT2B7D was expressed in a DmG/uRA+ 
background (Figure 2.3.1 0). These results support the notion that CaMKII is a 
critical intermediate in the ability of ligand-activated DmGiuRA to activate PI3K. 
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Figure 2.3.1 0: The increased excitability conferred by DmG/uRA 112b is suppressed 
by expression of the activated CaMKIIT287D. Mean number of stimulations 
(geometric means +/- SEMs) required to induce L TF (Y axis) at the indicated 
stimulus frequencies (X axis). The bath solution contained 0.15 mM [Ca2+] and 
100 1-1M quinidine. From top to bottom (D42>+, DmG/uRA tt2b,· D42>+, 
DmG/uRAtt2b, D42>CaMKffT2B7D, and DmG/uRAtt2b; D42>CaMKffT2B7D), n = 7, 8, 
6, 18, and 18 respectively, for each genotype. One-way ANOVA and Fisher's LSD 
gave the following differences, at 10 Hz, 7 Hz, 5 Hz and 3 Hz, respectively: For 
D42>+ vs. DmG/uRAtt2b, p=0.001, <0.001, <0.001, <0.001; vs. DmG/uRAtt2b; 
D42>+, p=0.031, 0.007, 0.002, <0.001; vs. D42>CaMK/fT2B70, p=0.001, 0.006, 
0.007, 0.011; vs. DmG/uRAt12b; D42>CaMKffT2B7o, p=0.016, 0.013, 0.045, 0.011. 
For DmG/uRAtt2b,· D42>+ vs. DmG/uRAtt2b, p=0.203, 0.256, 0.218, 0.650; vs. 
DmG/uRAt12b; D42>CaMKffT2B7D, p<0.001, <0.001, <0.001, <0.001. For 
DmG/uRAt12b; D42>CaMKffT287D vs. D42>CaMKffT287D, p=0.725, 0.745, 0.642, 
0.897. Pvalues <0.05 were considered statistically significant. 
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2.4 Summary 
In both mammalian central synapses and Drosophila larval motor neurons, 
activation by glutamate of the metabotropic glutamate receptor (mGiuR) activates 
the lipid kinase PI3K, but the mechanism by which this activation occurs has not 
been elucidated. Here we identify the Calcium/calmodulin-dependent kinase II 
(CaMKII) as a critical intermediate in the ability of the single Drosophila mGiuR 
(DmGiuRA) to activate PI3K, and show that the ability of both activated DmGiuRA 
and CaMKII to activate PI3K requires the nonreceptor tyrosine kinase Focal 
adhesion kinase (DFak) (Figure 2.3.11 ). These results provide novel insights into 
the mechanism by which DmGiuRA activation triggers the observed 
down-regulation of subsequent neuronal activity in Drosophila motor neurons. 
These results might also be relevant to the mechanism by which mGiuR activates 
PI3K in mammalian central synapses, a process implicated in fragile X, autism 
spectrum disorders (ASD), Neurofibromatosis and tuberous sclerosis (Kelleher 
and Bear, 2008). 
How might CaMKIIIead to the DFak-dependent activation of PI3K? Although 
the ability of CaMKII to activate PI3K has only recently been reported (Ma et al., 
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2009), it has been well established in mammals that CaMKII phosphorylates both 
Fak and Pyk2 on multiple serines on the C terminus. These phosphorylation 
events can activate Pyk2 by enabling subsequent tyrosine phosphorylations 
(particularly at Tyr402) via mechanisms that are incompletely understood (Della 
Rocca et al., 1997; Fan et al., 2005; Heidinger et al., 2002; Montiel et al., 2007; 
Soltoff, 1998; Zwick et al., 1999). It has also been well established that Fak and 
Pyk2, when activated by tyrosine phosphorylation, are each able to activate PI3K: 
tyrosine-phosphorylated Fak binds p85, the PI3K regulatory subunit, via both the 
SH3 and SH2 domains (Chen et al., 1996; Chen and Guan, 1994; Guinebault et 
al., 1995). In addition, both tyrosine-phosphorylated Fak and Pyk2 are capable of 
activating Ras via the conserved Grb2-SoS pathway (Avraham et al., 2000; Dikic 
et al., 1996; Rocic et al., 2001; Schlaepfer et al., 1994), which could in principle 
lead to the Ras-dependent, pBS-independent activation of PI3K. These 
observations raise the possibility that Drosophila CaMKII might similarly activate 
PI3K by directly phosphorylating and activating DFak. Alternatively, DFak might 
function in a more indirect fashion, perhaps as a scaffold linking CaMKII and PI3K 
in a signalling complex. This alternative possibility would suggest that additional 
intermediates linking CaMKII and PI3K activation exist but are currently 
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unidentified. 
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Figure 2.3.11: A proposed mechanism for the DmGiuRA-dependent activation of 
PI3K via CaMKII and DFak. We suggest that glutamate released from motor 
nerve terminals as a consequence of neuronal activity activates DmGiuRA 
autoreceptors located in motor nerve terminals. This DmGiuRA activation then 
activates CaMKII, which phosphorylates and activates DFak. The formation of 
phospho-tyrosylated DFak recruits and activates PI3K, either via the p85 
regulatory subunit or via Ras. The ability of DmGiuRA to activate CaMKII implies 
that DmGiuRA activation increases intracellular [Ca2+], although this possibility 
has not been tested. As shown previously (Howlett et al., 2008), PI3K activation 
decreases neuronal excitability by inhibiting the transcription factor Foxo, and 
increases synapse number by activating S6 kinase. 
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The observation that DmGiuRA-mediated activation of PI3K requires CaMKII 
implies that DmGiuRA activation increases intracellular Ca2+ levels in Drosophila 
motor nerve terminals as a necessary step in PI3K activation. The source of Ca2+ 
for this activation is not known. However, it is well established that in mammals, 
activation of group I mGiuRs, which are responsible for mGiuR-mediated LTD in 
the hippocampus and cerebellum, induce phospholipase C and IP3-mediated 
Ca2+ transients (Pin et al., 1994): which are essential intermediates in cerebellar 
mGiuR-mediated LTD (Ito, 2001 ). Although Drosophila DmGiuRA is most similar 
to mammalian group II mGiuRs, which are not known to activate Ca2+ transients, 
given that DmGiuRA is the sole mGiuR in Drosophila, it seems possible that 
DmGiuRA might carry out many of the functions carried out by each of the three 
groups of mGiuRs in mammals, as suggested previously (Pan et al., 2008). 
Alternatively, it is possible that DmGiuRA activation might increase intracellular 
Ca2+ via the ryanodine receptor, which was previously shown to be an essential 
activator of CaMKII in Drosophila larval motor nerve terminals (Shakiryanova et 
al., 2007). 
The ability of CaMKII to activate PI3K requires the nonreceptor tyrosine 
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kinase DFak: the DFaf<CGt null mutation completely blocks the ability of glutamate 
applied to motor nerve terminals to activate PI3K, completely suppresses the 
increase in basal p-Akt levels conferred by CaMKJfT2B7D, and blocks the ability of 
CaMKIIT2B7D to confer two additional PI3K dependent phenotypes: increased 
synapse number at the NMJ and increased motor axon diameter. These results 
identify DFak as an essential intermediate in PI3K activation by DmGiuRA and 
CaMKII. However, DFaf<CGt mutants fail to exhibit other phenotypes conferred by 
decreased PI3K activity: in an otherwise wildtype background, DFaf<CGt larvae 
exhibit only minor effects on NMJ synapse number or motor axon diameters, 
which are each significantly decreased by decreased PI3K (Howlett et al., 2008; 
Martin-Pena et al., 2006). These results raise the possibility that whereas PI3K 
activation by DmGiuRA and CaMKII is blocked in DFaf<CGt, total PI3K activity is 
not strongly decreased because other significant routes to PI3K activation are 
DFak-independent. Alternatively, DFak might participate in signaling pathways 
distinct from the CaMKII-DFak-PI3K pathway we have identified, which would 
oppose the effects of PI3K on synapse number and axon diameter. In this view, 
CaMKII would preferentially promote the ability of DFak to activate PI3K, rather 
than other DFak-dependent pathways. 
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In several subregions of the mammalian brain, ligand activation of group I 
mGiuRs induces a type of synaptic plasticity called long term depression (L TO). 
This induction both activates and requires the activity of PI3K as well as the 
PI3K-activated kinase Tor (Hou and Klann, 2004; Ronesi and Huber, 2008). 
Several lines of evidence have led to the proposal that increased sensitivity to 
mGiuR-mediated LTD induction might underlie specific neurogenetic disorders. In 
particular, mice null for the gene affected in Fragile X, which is associated with an 
extremely high incidence of autism as well as other cogitive deficits, exhibit 
increased sensitivity to mGiuR-mediated LTD induction in both the hippocampus 
(Huber et al., 2002) and cerebellum (Koekkoek et al., 2005). Furthermore, the 
genes identified in two additional diseases associated with a high incidence of 
autism, Neurofibromatosis (Nf1) and tuberous sclerosis (Tsc1 and Tsc2), each 
encode negative regulators of the PI3K pathway: Nf1 encodes a Ras GTPase 
activator protein (Xu et al., 1990), which inhibits the P13K activator Ras 
(Rodriguez-Viciana et al., 1994) whereas the Tsc proteins are Tor inhibitors that 
are in turn inhibited by PI3K activity (Gao et al., 2002; lnoki et al., 2002). Thus 
loss of Nf1 or Tsc might also increase sensitivity to mGiuR-mediated LTD. Finally, 
several lines of direct evidence suggest that PI3K hyperactivation plays a causal 
90 
role in autism (Butler et al., 2005; Kwon et al., 2006; Mills et al., 2007; Serajee et 
al., 2003). For example, DNA copy number variants observed in individuals with 
autism but not unaffected individuals identify at high frequency PI3K subunits or 
regulators, and each genetic change is predicted to elevate PI3K activity (Cusco 
et al., 2009). In addition, a translocation that increases expression of the 
translation factor eiF-4E, which is known to be activated by the PI3K pathway 
(Miron et al., 2003; Puig et al., 2003), plays a direct, causal role in autism 
(Neves-Pereira et al., 2009). The potential involvement of mGiuR-mediated LTD 
in these neurogenetic disorders increases interest in identifying the molecular 
intermediates that participate in this pathway, but these intermediates are for the 
most part unidentified. Thus the possibility that CaMKII and Fak might participate 
in mGiuR-mediated PI3K activation in mammals as well as Drosophila might have 
significant medical interest. 
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Chapter 3: Pumilia may regulate neuronal excitability via the mGiuR/ 
PI3K signal transduction pathway and transcription factor 
Foxo 
3.1 Synopsis 
According to our previous studies (Howlett et al., 2008) and chapter 2, we 
have found that the mGiuR/PI3K pathway regulates motor neuron excitability, and 
we have identified CaMKII and DFak as two critical intermediates for the 
DmGiuRA-mediated activation of PI3K. In addition, we also reported that 
overexpression of Foxo+ increased the rate of onset of L TF, basal transmitter 
release and frequency of successful EJPs to a level very similar to that observed 
when PI3K pathway activity was decreased (Figure 3.1.1) whereas in 
Foxo21/Foxo2s larvae, the rate of onset of LTF, basal transmitter release and 
frequency of successful EJPs were decreased to levels very similar to those 
observed when P/3K-CAAX was expressed in motor neurons (Figure 3.1.1) 
(Howlett et al., 2008). Therefore, these results suggest the transcription factor 
Foxo acts as a downstream effecter of PI3K to regulate motor neuron excitability 
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(Howlett et al., 2008). In summary, in response to nerve stimulation, the 
consequent release of glutamate (the excitatory neurotransmitter) from motor 
nerve terminals down-regulates neuronal excitability by activating metabotropic 
glutamate receptors (mGiuRs) in the same nerve terminal, and furthermore, this 
downregulation of excitability occurs by mGiuR-dependent activation of PI3K and 
Akt and the consequent inhibition of Foxo (Figure 3.1.2) (Howlett et al., 2008). 
This PI3K/Foxo-mediated function serves as an activity-dependent inhibition of 
neuronal activity (negative feedback). However, the Foxo transcriptional targets 
mediating this control of neuronal excitability were not identified. 
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Figure 3.1.1: Foxo mediates the effects of P/3K on motor neuron excitability. The 
Ga/4 driver D42 was used to drive expression of transgenes in all genotypes 
except for Foxo21/Foxo25; OK6>P/3J<DN, in which the motor neuron driver OK6 
was used and which behaves similarly to D42 in this assay. For all L TF 
experiments, the bath solution contained 0.15 mM [Ca2+] and 100 1-1M quinidine. A) 
Representative traces showing the decreased rate of onset of L TF (I) and 
decreased ejp amplitude (II) in Foxo21/Foxo2Siarvae compared to wildtype at the 
indicated [Ca2+], and the increased rate of onset of L TF and ejp amplitude in 
larvae overexpressing Foxo. Arrowheads indicate the increased and 
asynchronous ejps, indicative of onset of L TF. In (II), representative traces are 
averages of multiple ejps. From top to bottom, n= 23, 180, and 34 respectively. B) 
Number of stimulations required to induce L TF (Y axis) at the indicated stimulus 
frequencies (X axis). Geometric means+/-SEMs are shown. From top to bottom, 
n = 12, 6, 7, 18, 10, 21, 5, and 9 respectively, for each genotype. One-way 
AN OVA and Fisher's LSD gave the following differences, at 10 Hz, 7 Hz, 5 Hz and 
3 Hz, respectively: For D42>+ vs. Foxo21/Foxo2s, p = 0.0096, 0.0069, <0.0001 , 
0.0007; vs. D42>Foxo+, p = 0.0026, 0.0012, <0.0001 , 0.0065. For 
D42>P/3K-CAAX, Foxovs. D42>P/3K-CAAX, p = 0.0041, 0.0005, 0.0002, 0.0006; 
vs. D42>Foxo, p = 0.50, 0.43, 0.16, 0.14. For Foxo21Foxo2s; OK6>P/3J<DN vs. 
OK6>P/3J<DN, p = ; 0.0003, 0.0004, 0.0014, 0.001. vs. Foxo21Foxo2s, p = 0.63, 
0. 7 4, 0.43, 0.20. P values <0.05 were considered statistically significant (Howlett 
et al. , 2008). 
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Several previous papers have reported that alterations of the translational 
repressor pumi/io (pum) and the sodium channel paralytic (para) also affect 
neuronal excitability in motor axons. First, in Drosophila, pum null mutants, motor 
neuron excitability is increased, and this phenotype is similar to the phenotype 
conferred by overexpression of Para in motor neurons (Schweers et al., 2002; 
Stern et al., 1990). In contrast, overexpression of Pum and loss of Para in the 
nervous system reduce neuronal excitability (Schweers et al., 2002; Stern et al., 
1990). Second, Pum binds directly to para mRNA and inhibits the Para translation; 
which decreases sodium current and excitability in Drosophila motor neurons 
(Mee et al., 2004; Muraro et al., 2008). Third, I also found that there are three 
potential Foxo binding sequences ((G/A)TAAA(C/T)A) within 1 Kb of genomic 
DNA from the pum 5' extended gene region (Curran et al., 2009; Demontis and 
Perrimon, 2010; Teleman et al., 2008) (Table 3.1.1). In addition, inhibiting the 
mGiuR/PI3K signaling pathway also increases neuronal excitability, and this 
phenotype is similar to pum null mutants (Howlett et al., 2008; Schweers et al., 
2002). Therefore, I hypothesized that Pum and Para may function as downstream 
signaling molecules of Foxo in the mGiuR/PI3K-mediated negative feedback. 
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Promoter Region Foxo Binding 
Consensus Sequence 
Position Sequence 
Pum (CG9755) (-405) ATAAATA 
promoter (G/A)TAM(CIT)A {-453) ATAAATA 
(3R:5063417 ,5064417) (-646) ATAAATA 
Table 3.1.1: The potential Foxo binding sequences in 5' extended gene region of 
pum. 
Therefore, we hypothesize that Foxo activity increases neuronal excitability 
by directly binding to and repressing transcription of pum (Figure 3.1.2). This 
transcriptional repression was predicted to increase neuronal excitability because 
Pum inhibited the transcription of para (Mee et al., 2004). Therefore, Foxo activity 
is proposed to increase sodium channel levels, conferring increased neuronal 
excitability (Howlett et al., 2008). To test this hypothesis, anti-Pum antibody was 
applied to measure the expression level of Pum in the Drosophila central nervous 
system (CNS). Therefore, if Foxo does inhibit the transcription of pum directly, we 
predict that activating PI3K or inhibiting Foxo will increase Pum protein levels. 
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Figure 3.1.2: A proposed mechanism for the mGiuR/PI3K/Foxo-mediated 
negative regulation of neuronal excitability via Pum and Para. Glutamate released 
from motor nerve terminals as a consequence of neuronal activity activates 
DmGiuRA autoreceptors located in motor nerve terminals. This DmGiuRA 
activation then activates PI3K. PI3K activation decreases neuronal excitability by 
inhibiting the transcription factor Foxo. The inhibition of Foxo activity may 
suppress the expression of Pum and then Para will be increased; furthermore, the 
alteration of Para will affect neuronal excitability and control presynaptic 
glutamate release. 
3.2 Materials and Methods 
3.2.1 Drosophila stocks 
For all experiments, Drosophila larvae were reared on standard cornmeal/ 
agar media at 22-23°. Flies carrying the UAS-PJ31(DN (D954A) and 
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UAS-P/3K-CAAX transgenes (Leevers et al., 1996), encoding a 
dominant-negative and constitutively active PI3K, respectively, were provided by 
Sally Leevers (London Research Institute, London, UK). Flies carrying the 
UAS-Foxo+ transgene was provided by Marc Tatar (Brown University, 
Providence, Rl). Flies carrying the Foxo2t and Foxo25were provided by Heinrich 
Jasper (University of Rochester, Rochester, NY). All other fly stocks were 
provided by the Drosophila stock center (Bloomington, IN). 
3.2.2 Immunocytochemistry 
Antibodies against Drosophila Pumilio (Pum) were kindly provided by Dr. 
Lehmann (New York University) and were used at 1:500 dilution. Dylight™ 
594-conjugated goat anti-rabbit lgG (Jackson lmmunoResearch) was used at a 
dilution of 1:500. For ventral ganglion staining, larvae were dissected in PBS and 
fixed in 4% paraformaldehyde. Images were taken on a Zeiss 510 LSM with a 63x 
objective. Z-stacks were compiled from 2 1Jm serial sections to a depth adequate 
to encompass the 10 IJm thickness for each sample. lmageJ software was used to 
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analyze pumilio intensities. In particular, 20 projections were created using the 
average pixel intensity and cell area was traced using the freehand selection tool 
and the selection where the mean pixel intensity value was measured. Two 
different areas of each sample and five samples of each genotype were selected 
for analyzing Pumilia. The mean intensity of Pum level of wild type was used for 
reference. Bars represent mean Pumilia levels +/-SEMs. 
3.3 Results 
3.3.1 The protein level of pumilio is increased in Foxo null mutants in the 
Drosophila ventral ganglion 
Based on the model, Foxo might regulate neuronal excitability by inhibiting 
pum transcription, which results in the decrease of Pum levels. Because this 
translational machinery lies close to the nucleus of the cell, I hypothesize that this 
translational event will take place within the motor neuron cell body which is 
located in the Drosophila ventral ganglion. Therefore, if Foxo inhibits pum 
transcription, I predict that Pum protein level should be elevated in Foxo null 
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mutants within the motor neuron cell body. To test this hypothesis, first, I 
monitored the expression level of Pum following application of an antibody against 
Pum and measured the fluorescence intensity of Pum in the ventral ganglion in 
wild type and Foxo21!Foxo2Siarva. As shown in Figure 3.3.1, we found that Pum 
levels in Foxo null flies were significantly increased (Figure 3.3.1 ). 
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Figure 3.3.1 : The inhibition of Foxo activity increases the expression of Pum. Left 
panel: Representative confocal images of third instar larval ventral ganglion of 
wildtype ( +/+) and Foxo21/Foxo25 stained with anti-Pum. All images are taken from 
different larvae. Right panel: Mean normalized Pum intensity (Y axis) +/- SEM for 
the following genotypes (X axis): +>+and Foxo21/Foxo25. Pixel intensities were 
quantified using lmageJ software. The normalized Pum intensities are shown as a 
ratio change compared to wild type. From left to right, n = 5, 5, respectively, . for 
each genotype. Student T -test was performed for statistical analysis. P values 
<0.05 were considered statistically significant. 
Next, we wanted to know whether overexpression of Foxo can inhibit the 
Pum expression and examine whether this potential transcriptional regulation is 
occurring in the motor neuron. We used the motor neuron driver 042 (Sanyal, 
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2009) to overexpress both Foxo+ and green fluorescence protein (GFP). GFP was 
used for labeling motor neurons. Here, we found that overexpression of Foxo 
suppressed the expression level of Pum in motor neurons (Figure 3.3.2). In 
conclusion, Foxo is a negative regulator of Pum. 
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Figure 3.3.2: Foxo activity suppresses the expression of Pum. (A) Representative 
confocal images of third instar larval ventral ganglion of 042 > GFP, +, and 042 > 
GFP, Foxo+ stained with anti-Pum (left panels), GFP (middle panels), and merged 
images (right panels). (B) Mean normalized Pum intensity (Y axis) +/- SEM for the 
following genotypes (X axis): 042 > GFP, +, and 042 > GFP, Foxo+. Pixel 
intensities were quantified using lmageJ software. The normalized Pum 
intensities are shown as a ratio change compared to wild type. From left to right, n 
= 5, 5, respectively, for each genotype. Student T-test was performed for 
statistical analysis. Pvalues <0.05 were considered statistically significant. 
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3.3.2 Manipulation of the P13K signaling pathway within the Drosophila ventral 
ganglion affects pumilio protein levels 
As described above, the expression of pumilio is inhibited by Foxo. Foxo has 
also been shown to be a downstream effector of mGiuR/PI3K signaling, and 
mGiuR/PI3K/Foxo negatively regulates neuronal excitability at motor neuron 
terminals (Howlett et al., 2008). Therefore, we predict that the manipulation of 
signaling molecules within the PI3K pathway will also alter the expression of Pum. 
To test this prediction, we used the central nervous system driver Elav (Sanyal, 
2009) to overexpress both P/3J<DN and Pten. Because the overexpression of 
P/3J<DN and Pten block PI3K signaling and prevent the inhibition of Foxo, I 
hypothesized that the expression of pum will be suppressed in both Elav > PTEN 
and Elav > P/3J<DN. As shown in Figure 3.3.3, the expression of pum in Elav > 
P/3J<DN decreased about 20% and in Elav > Pten decreased about 15% (Figure 
3.3.3). Taken together, these results confirmed that pum is required for 
mGiuR/PI3K/Foxo-mediated negative regulation to maintain neuronal 
homeostasis. 
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Figure 3.3.3: The decrease of PI3K activity suppresses the expression of Pum. 
(A) Representative confocal images of third instar larval ventral ganglion of +/+, 
Foxo21/Foxo25, Elav > P/JJ<DN, and Elav > Pten stained with anti-Pum. (B) Mean 
normalized Pum intensity (Y axis) +/- SEM for the following genotypes (X axis): 
+/+, Foxo21/Foxo25, Elav > PIJJ<DN, and Elav > Pten. Pixel intensities were 
quantified using lmageJ software. The normalized Pum intensities are shown as a 
ratio change compared to wild type. From left to right, n = 5, 5, 5, 5, respectively, 
for each genotype. Student T-test was performed for statistical analysis. Pvalues 
<0.05 were considered statistically significant. 
105 
3.4 Summary and future work 
Here I showed that the translational repressor pumilio (pum) may function as a 
downstream effector in the regulation of presynaptic neuronal homeostasis. 
However, there are still many questions and concerns that need to be addressed. 
First, to confirm that disruptions of genes involved in mGiuR/PI3K/Foxo negative 
feedback alter the expression of Pum and Para in Drosophila ventral ganglion, 
Q-PCR will be performed to measure pum and para transcript level in larva that 
have genetic disruptions in mGiuR/PI3K/Foxo-mediated signaling molecules. 
Second, Chromatin lmmunoprecipitation (ChiP) assays will be utilized to identify 
the Foxo binding region in the pum 5' UTR. Third, Third instar larvae with puf71Jem, 
Foxo21/purn"em, Foxo2s or puf71Jem, D42>P/3K-CMX will be characterized on 
phenotypic changes, including neuronal excitability and neuronal arborization. 
These experiments may be able to elucidate the relationship of Pum and Para in 
mGiuR/P13K/Foxo-mediated negative feedback mechanism. 
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Chapter 4: Drosophila Push may regulate neuronal homeostasis and 
retrograde signaling in neuromuscular junction 
4.1 Synopsis 
The ubiquitin proteosome system (UPS) has been implicated in regulating 
synapse development, presynaptic function, and neurotransmitter release (Yi and 
Ehlers, 2005). For example, in 2001, DiAntonio's lab reported that the 
overexpression of the deubiquitinating protein fat facets (faf) in the Drosophila 
nervous system significantly increased the number of synaptic boutons and 
arbors (DiAntonio et al., 2001). Moreover, the overexpression of faf also 
decreases both the quantal content of excitatory junction potential (EJP) and the 
frequency of spontaneous miniature EJPs (mEJPs). Simultaneously, the data also 
showed that loss-of-function of highwire (hiW), an E3-ubiquitin ligase, had a 
similar phenotype to fafgain-of-function (DiAntonio et al., 2001). Recently, UPS 
and endoplasmic reticulum (ER)-associated protein degradation (ERAD) have 
been further implicated in the regulation of neuronal excitability. Altier et al. 
reported that a mammalian L-type voltage-gated calcium channel subunit, Cav1.2, 
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underwent robust ubiquitination by the RFP2 ubiquitin ligase and degradation by 
the proteasome in the absence of the accessory subunit CavJ3 (Altier et al., 201 0). 
This finding indicated that CavJ3 and UPS are required to regulate the density of 
Cav1.2 and maintain proper neuronal activity (Altier et al., 2010). In addition, Fu et 
al, reported that activation of the ephrin type-A receptor 4 (EphA4) induced the 
degradation of GluR1, a subunit of the a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor (AMPAR), through ubiquitin ligase 
anaphase-promoting complex (APC) and proteasomes. The consequent 
decrease in the quantity of synaptic and surface GluR1 then resulted in a 
reduction of mEPSC amplitude (Fu et al., 2010). These results indicated that 
EphA4 regulated the density of GluR1 subunit of the AMPAR via a UPS 
degradation pathway (Fu et al., 2010). Based on these findings, the UPS and 
ERAD have emerged as important regulators in maintaining neuronal excitability 
and homeostasis (Kantamneni et al., 2011). 
As mentioned in chapter 1, push has been predicted to be an E3-ubiqutin 
ligase (Yager et al., 2001). Our previous studies showed that push also plays an 
important role in the regulation of neuronal excitability. In push null mutants, both 
larvae and adults exhibit several severe behavioral defects, which are the 
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consequence of neuronal defects. Adults with push mutations exhibit an inability 
to fly, uncoordination, sluggishness, and lack of an escape response (Richards et 
al., 1996). Third instar larvae with push mutations demonstrate an increase both 
in neurotransmitter release (EJP amplitude increase) and in the frequency of 
mEJPs in the neuromuscular junction (Richards et al., 1996) (Figure 4.1.1 ). Even 
though these previous studies already indicated that Push is required to maintain 
neuronal homeostasis, the cellular location and functional properties of Push and 
Push-mediated molecular pathways remained a mystery. 
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Figure 4.1.1 : push mutations increase neurotransmitter release and the frequency 
of single vesicle release (represented as mEJPs) in the motor neuron. (A) Top 
Left panel: representative traces showing the increased excitatory junction 
potential (EJP) amplitude in push1fpush1 larvae at a bath [Ca2+] of 0.15 mM, 0.4 
mM and 1.0 mM in Jan's solution. Bottom left panel: mean EJP amplitudes +/-
SEMs (Y axis) at the indicated [Ca2+] (X axis), from the following genotypes: wild 
type and push1/push1 (push). n = (12, 7, 5) respectively, for each genotype and 
[Ca2+] (0.15 mM, 0.4 mM and 1.0 mM in Jan's bufffer). (B) Top right panel: 
representative traces showing the increased of frequency of mini EJPs in 
push1fpush1. Three traces from each genotype are from three different larvae. 
Bottom right panel: Mean mEJP frequency +/- SEMs (Y axis) for the indicated 
genotypes (X axis): wild type and push1fpush 1. Recordings were collected from 
twelve different larvae from each genotype in Jan's solution with a bath [Ca2+] of 
0.15 mM, and total number of responses within 5 seconds period were measured 
and averaged from each larva. The asterisk indicated P values <0.05 and are 
considered statistically significant. (Data is adopted from Richards et al., 1996). 
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Therefore, in this chapter, I will be focused on characterizing the role of Push 
in the Drosophila neuromuscular systems. Three avenues of investigation will be 
described in this chapter including 1) the expression pattern of Push in Drosophila, 
2) the role of push in the regulation of neurotransmitter release, and 3) the role of 
push in the regulation of homeostasis at the Drosophila neuromuscular junction. 
4.2 Materials and Methods 
4.2.1 Drosophila stocks 
For all experiments, Drosophila larvae were reared on standard cornmeal/ 
agar media at 22-23°. pusht/CyoGFP (1481G and 1481C) and pusf12/CyoRoi 
(S1516D) were generated in our lab (Richards et al., 1996). Flies carrying the 
UAS-P/3K-CAAXtransgene (Leevers et al., 1996), encoding constitutively active 
PI3K, were provided by Sally Leevers (London Research Institute, London, UK). 
Flies carrying the UAS-pusf1RNAi (14472R-1), UAS-PLCPRNAi (4574R-1) and 
UAS-IP3RRNAi (1063R-1) transgenes, were provided by National Institute of 
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Genetics (Shizuoka, Japan). Flies carrying the UAS-mG/uRRNAi, were provided by 
Marie-Laure Parmentier (Unite Propre de Recherche Centre, Montpelier, France). 
Flies carrying the UAS-IP3RRNAi transgenes, were provided by Vienna Drosophila 
RNAi Center (Vienna, Austria). All other fly stocks were provided by the 
Drosophila Stock Center (Bloomington, IN). 
4.2.2 Push antibody production 
The push fragment (named as push3499), which was used for antibody 
production, was from amino acids 3499 to 3894 within the push C-terminus, and 
its molecular weight is about 45.8 kDa. The gene fragment encoding push3499 
was cloned from a bacteria artificial chromosome (BAC) BACR08101 (Berkeley 
Drosophila Genome Project, Berkeley, CA) with the following pair of primers 
(5'-CAT ATG GCC TCC GGA AAA CTT CGA ACA GAT CG-3' and 5'-CTC GAG 
TT A CTC CAG CAT TTG CTT GTT GGT CAG CAG-3'). Ndel and Xhol restriction 
enzymes sites were used to clone push3499 gene fragments into E. coli 
expression vector pET19A (lnvitogen). The recombinant plasmids 
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(pET19A-push3499) were transformed into E. coli stain BL21(DE3) for protein 
expression. The cells were grown overnight in LB medium. The overnight culture 
was inoculated in the TB medium with 1 OOOX dilution. When the cell population 
reached 0.6 in O.D. 360, the push3499 cells were induced by adding IPTG to a 
final concentration of 1 mM at 37°C. The expression level of push3499 was tested 
by collecting 2 and 4 hours induction cultures and detecting protein on 15% 
SDS-PAGE. After induction, the cells were broken and total protein was extracted 
in Hepes buffer (25 mM HEPES, 100 mM KCI, 10% (w/v) glycerol, pH 7.4) with 
cOmplete ULTRA Protease Inhibitor Tablets (Roche). Push3499 was purified by 
Ni-NTA under Hepes buffer with gradient imidazole (0-500 mM) and concentrated 
to 1 mg/ml. The antibody production of push3499 was carried out by COCALICO 
BIOLOGICAL, INC. (Reamstown, PA) using the following procedure (Table 4.1.1 ). 
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DayO 
Day 21 
Day42 
Day 52 
Day63 
Day73 
Day84 
Day94 
Day 105 
Day 115 
Day 126 
Day 136 
Day 147 
Day 157 
Day 168 
Day 178 
Primary injection of 200 IJQ/rabbit in complete Freund's adjuvant 
Secondary injection of 1 001JQ /rabbit in incomplete Freund's adjuvant 
Boost injection of 1 OOIJQ /rabbit in incomplete Freund's adjuvant 
Test Bleed rabbit 
Boost injection of 1 001JQ /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #1 
Boost injection of 1 OOIJQ /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #2 
Boost injection of 1001-19 /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #3 
Boost injection of 1 OOIJQ /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #4 
Boost injection of 1 OOIJQ /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #5 
Boost injection of 1 001JQ /rabbit in incomplete Freund's adjuvant 
Production Bleed rabbit #6 
Table 4.1.1: The procedure of push3499 production 
4.2.3 Immunohistochemistry 
Larvae were grown to the wandering third-instar stage in uncrowded 
half-pint bottles. Larvae were collected for experimentation only during the first 
and second days after the initial wandering third-instar larvae appeared. For push 
immunostaining, larvae were dissected in standard Phosphate Buffered saline 
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(PBS, 0.128 M NaCI, 2.0 mM KCI, 4.0 mM MgCI2, 0.34 M sucrose, 5.0 mM 
HEPES, pH 7.1, and 0.15 mM CaCI2) and fixed in PBS containing 4% 
paraformaldehyde. Fixed larval tissues were incubated with a rabbit 
anti-Drosophila push (push3499) polyclonal primary antibody (1 :500 dilution). 
Larvae were then incubated with Rhodamine Red conjugated goat anti-rabbit lgG 
(1 :500 dilution, Jackson lmmunoResearch), and Cy-2 conjugated antibodies 
against horseradish peroxidase (1 :200 dilution, Jackson lmmunoResearch). 
lmmuno-labeled larval tissues in PBS containing 50% glycerol were mounted onto 
slides. Larval tissues including brain, ventral ganglion, and muscle were imaged 
on a Zeiss LSM 510 confocal microscope system (Zeiss, Oberkochen, Germany) 
with a 20X and 63X objective lens. Optical sections were 1 or 2 1-1m thick. Optical 
parameters, including pinhole, gain, contrast, and brightness, were held constant 
for each experimental set. The protocol of Drosophila S2 cells immunostaining 
was the same as larvae immunostaining. For phosphorylated Mad (p-Mad) 
immunostaining, larvae were dissected in Schneider's Drosophila media (Gibco) 
and fixed in Schneider's Drosophila media containing 4% paraformaldehyde. 
Fixed larval tissues were incubated with a rabbit anti-p-Mad polyclonal primary 
antibody (1 :500 dilution) (provided by Peter ten Dijke, Ph.D., Leiden, The 
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Netherlands) (Persson et al., 1998). Larvae were then incubated with Rhodamine 
Red conjugated goat anti-rabbit lgG (1 :500 dilution, Jackson lmmunoResearch), 
and Cy-2 conjugated antibodies against horseradish peroxidase (1 :200 dilution, 
Jackson lmmunoResearch). Mounting procedures are as described above. 
Neuromuscular junctions (NMJs) from muscles 6 and 7 in segments A2 to A5 
were imaged on a Zeiss LSM 510 confocal microscope system (Zeiss, 
Oberkochen, Germany) with a 63X objective. Optical sections were 1 !Jm thick. 
Optical parameters, including pinhole, gain, contrast, and brightness, were held 
constant for each experimental set. 
4.2.4 Electrophysiology 
Larvae were grown and selected as described above and dissected in HL3 
buffer (70 mM NaCI, 5.0 mM KCI, 20 mM MgCI2, 10 mM NaHC03, 5 mM 
Trehalose, 115 mM sucrose, 5 mM HEPES, pH 7 .2, and CaCI2 concentration as 
specified in the text). Peripheral nerves were cut immediately posterior to their exit 
from the ventral ganglion, and were stimulated with a suction electrode at a 5V 
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stimulus intensity. Muscle recordings were taken from muscle 6 in abdominal 
sections 3-5. Stimulus duration, approximately 0.05 msec, was adjusted to 1.5 
times threshold which reproducibly stimulates both axons innervating muscle 6. 
Intracellular recording electrodes for muscle potentials were pulled with a 
Flaming/Brown micropipette puller to a tip resistance of 10-40 MO and filled with 
3M KCI. Excitatory junction potential (EJP) amplitude are reported as geometric 
means because the data show a positive skew. 
4.2.5 20-Difference in gel electrophoresis (20-DIGE) and protein identificaiton 
The total protein samples were extracted from Drosophila heads of wild type 
and push null mutants. The protein concentration of each fraction was determined 
by 2-D Quant (GE lifescience). 25 ~g of the wild type protein sample was labeled 
with Cy2 and 25 ~g of the push null mutant sample was labeled with Cy3. The 
fluorophore-labeling and gel electrophoresis were performed by Applied Biomics, 
Inc. (Hayward, CA). 96 potential protein spots showing differential expression 
were collected for protein identification. The in-gel digestion and protein 
identification were also carried out by Applied Biomics, Inc. 
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4.3 Results 
4.3.1 Push is a membrane protein and may also associate with microtubule. 
Previous studies have suggested that Push may be a membrane protein 
based on computational prediction (Yager et al., 2001). However, there was no 
experimental evidence to confirm this prediction. To address this question, I 
produced the polyclonal a-push antibody (push3499), which recognizes the 
region from amino acid 3499 to 3894. Stack images of Push immunostaining on 
Drosophila early embryos showed that Push existed only on the membranes. 
Furthermore, three dimensional image reconstructions indicated that push is 
specifically present on the membrane (Figure 4.3.1 ). 
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Figure 4.3.1: Push is present on the membrane of Drosophila early embryo. Top 
panel: Representative stack confocal images of a Drosophila early embryo 
stained with anti-Push. The stack images were 2 IJm serial sections. Scale bar is 5 
IJm. Bottom panel: 3D image of Drosophila early embryo are reconstructed from 
the stack confocal images showed on the top panel. The semicircle was a 2D 
model to represent a single cell, marked by yellow arrow. 
To confirm this result, I applied the same immunostaining protocol, except in 
the absence of non ionic surfactant Triton X-1 00, on Drosophila S2 Cells. 
Simultaneously, the cytosolic housekeeping protein, J3-tubulin, was stained as the 
control. I hypothesized that the immunoreaction of J3 -tubulin will not occur 
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because the a-J3-tubulin antibody can not penetrate into the cytoplasm. In contrast 
the immunoreaction of push will not be affected if push is present on the 
membrane. As shown in Figure 4.3.2, Push, but not ~-tubulin, is detected, these 
confirming my prediction (Figure 4.3.2). I conclude that push is a membrane 
protein. 
Figure 4.3.2: Push is present on the membrane of Drosophila 52 cells. (A) 
Representative stack confocal images of Drosophila S2 cell stained with 
anti-Push. The stack images were 1 1-1m serial sections to a depth. Scale bar is 5 
IJm. (B) Representative stack confocal images of Drosophila S2 cells stained with 
anti-~-tubulin . Scale bar is 5 IJm. (C) 30 image of Drosophila S2 cells are 
reconstructed from the stack confocal images of Push immunostaining. 
The mammalian P600 protein, which is an ortholog of Drosophila push, has 
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been reported as a novel microtubule-associated protein (MAP) and maintains ER 
stability (Shim et al., 2008). Therefore, I applied both a-push and a-~-tubulin 
antibodies to S2 cells and also used pre-immune serum (RCM3, the same serum 
before producing a-push antibody) as a control to examine whether push is also a 
MAP. We found that the push is co localized with ~-tubulin (Figure 4.3.3). These 
results indicated that push may also be a microtubule-associated protein in 
Drosophila melanogaster. 
Figure 4.3.3: Push is colocalized with microtubules. Representative confocal 
images of S2 cells stained with anti-Push (left panels), anti-J3-tubulin (center 
panels), and merged images (right panels). Scale bar is 5 IJm. 
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4.3.2 Push is highly expressed in the Drosophila nervous and muscular systems 
Drosophila Push has been implicated in the regulation of neurotransmitter 
release (Richards et al., 1996), spermatogenesis (Richards et al., 1996), and 
perineurial glial growth (Yager et al., 2001). The mammalian orthologue, p600, is 
characterized as a chromatin scaffold in the nucleus (Nakatani et al., 2005; Sakai 
et al., 2011 ). In the cytoplasm, p600 was also reported to be involved in the 
regulation of several events. First, p600 accompanies clathrin to regulate 
cytoskeletal organization and membrane morphogenesis (Nakatani et al., 2005). 
Second, p600 interacts with the endoplasmic reticulum (ER) and microtubules to 
maintain stability of the ER (Shim et al., 2008). Third, p600 is an E3-ubiqitin ligase, 
also called mammalian UBR4, and is tightly associated with the 26S proteasome 
(Besche et al., 2009; Tasaki et al., 2005). Fourth, p600 is implicated in the 
prevention on anoikis, a type of programmed cell death that is induced by 
improper cell-matrix interactions (Nakatani et al., 2005; Sakai et al., 2011). 
Therefore, p600 may also be important in the regulation of cell-cell and cell-matrix 
interactions. Because Drosophila Push and its mammalian ortholog perform 
several functions, this suggested that Push may be expressed in many types of 
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tissue. However, the global pattern of push in the Drosophila me/anogaster 
remains unclear. 
Here, because our lab is focusing on the Drosophila nervous and muscular 
systems, I chose the Drosophila third instar larva as a model organism to study 
the expression pattern of Push in nerves and muscles. First, I checked the 
expression of push in the Drosophila nervous system. As figure 4.3.4 shown, 
Push is highly expressed in both neurons and glia in the Drosophila brain and 
ventral ganglion (Figure 4.3.4A and Figure 4.3.48). Moreover, I found that Push 
may also be expressed in perineurial glia (Figure 4.3.4C). Second, in the 
Drosophila muscle, Push is highly expressed and the expression pattern of push 
seems to be dispersed among the actin filaments (Figure 4.3.4C). Therefore, 
push may also interact with actin filaments. In conclusion of section 4.3.1 and 
4.3.2, Push is expressed in both nervous and muscular systems. Moreover, 
because push seems to colocalize with cytoskeletal elements, including 
microtubules and actin filaments, these results may further indicate the 
importance of push in the regulation of vesicle trafficking, cell mobility, and muscle 
contraction. 
123 
(A) 
+I + 
(B) 
+/ + 
(C) 
+/ + 
Figure 4.3.4: Push is highly expressed in the Drosophila brain, ventral ganglion, 
glia, and muscle. (A) Representative confocal images of Drosophila brain stained 
with anti-Push (left panels), anti-HRP (middle left panels), DAPI (middle right 
panels), and merged images (right panels). Scale bar is 20 ~m. (B) 
Representative confocal images of Drosophila ventral ganglion stained with 
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anti-Push (left panels), anti-HRP (middle left panels), DAPI (middle right panels), 
and merged images (right panels). Scale bar is 20 1-Jm. (C) Representative 
confocal images of Drosophila nerve and muscle stained with anti-Push (left 
panels), anti-HRP (middle left panels), DAPI (middle right panels), and merged 
images (right panels). Scale bar is 20 1-Jm. 
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4.3.3 Push is required for maintaining proper neurotransmitter release at the 
Drosophila neuromuscular junction 
As mentioned above, push is highly expressed in the nervous system and 
. previous studies showed defects of neurotransmitter release in push nul/mutants. 
To understand whether this defect is caused by lack of push solely in the nervous 
system, I combined RNA interference ( UAS-pusf1RNA1 with central neuron driver 
E/av-ga/4 to knock down the expression level of push in neurons. However, as 
shown in Figure 4.3.5, the expression level of push in Elav > pusf1RNAi larval brains 
still remained similar to that of wild type. Therefore, the overexpression of Dicer 
(Ocr), an endoribonuclease which mediates the cleavage of double-stranded RNA 
(dsRNA) and pre-microRNA (miRNA) into short double-stranded RNA fragments, 
was introduced to enhance the efficacy of disruption of push mRNA and prevent 
push translation. By introducing Ocr together with pusflRNAi ( Elav >Dcr, 
pusflRNAi ), I was able to knock down the expression level of push dramatically in 
neurons (Figure 4.3.5). 
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Elav>Dcr, + 
Elav > pustJRNAI 
Elav > Dcr, pustJRNAI 
Figure 4.3.5: Elva> Ocr, pusf1RNAi can effectively knock down the expression of 
Push in Drosophila neuron cell. Representative confocal images of of third instar 
larval brains of Elav > Ocr, +, Elav > pusf1RNAi ,and Elav > Ocr, pusf1RNAi stained 
with anti-Push (left panels), anti-HRP (middle panels), and merged images (right 
panels). N indicated neuron cells. G indicated glia cells. Scale bar is 20 J,Jm. 
Since I was able to knock down push expression by genetic manipulation, 
next I asked if decreasing in push expression in neurons also increases 
neurotransmitter release similar to the push null mutation. To address this 
question, I performed electrophysiological recording on third instar neuromuscular 
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junctions. First, I compared the amplitude of excitatory junction potentials (EJPs) 
between wild type and push null mutants in HL3 solution. The EJP amplitudes of 
push null mutants were increased about 70% in both 0.4 mM and 0.6 mM [Ca2+]. 
These results confirmed the previous studies in our lab (Richards et al., 1996) 
(Figure 4.3.6A). Furthermore, the Elav > Ocr, pushRNAi also recaptured the same 
behaviors both in EJP amplitude and mEJP frequencies as well as push null 
mutants (Richards et al., 1996) (Figure 4.3.68 and Figure 4.3.6C). The results 
suggested that the defects of push mutants on neurotransmitter release result 
from loss of Push in neuron. 
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Figure 4.3.6: Loss of Push in neuron increase the EJP amplitude and mEJP 
frequency in the Drosophila NMJ. (A) Left panel: representative traces showing 
the increased excitatory junction potential (EJP) amplitude in push1 larvae at 
bath [Ca2+] of 0.4 and 0.6 mM in HL3 solution. Right panel: mean EJP amplitudes 
+1- SEMs (Y axis) at the indicated [Ca2+] (X axis), from the following genotypes: 
wild type and push1. Larval nerves were stimulated at a frequency of 1 Hz, and 30 
responses were measured and averaged from each nerve. n = 4, 4, 6, 6, 
respectively, for each genotype and [Ca2+] (0.4 mM and 0.6 mM). One-way 
ANOVA and Fisher's LSD gave significant differences at bath [Ca2+] as indicated 
on the figure. (B) Left panel: representative traces showing the increased 
excitatory junction potential (EJP) amplitude in push1 and Elav > Dcr, pus!JRNAi 
larvae at a bath [Ca2+] of 0.6 mM in HL3 solution. Right panel: mean EJP 
amplitudes +1- SEMs (Y axis) at the of 0.6 mM [Ca2+] (X axis), from the following 
genotypes: wild type, Elav > Dcr, +, push1, and Elav > Dcr, pus!JRNAi. Larval 
nerves were stimulated at a frequency of 1 Hz, and 30 responses were measured 
and averaged from each nerve. n = 6, 11, 6, 6, respectively, for each genotype in 
0.6 mM [Ca2+]. One-way ANOVA and Fisher's LSD gave significant differences at 
0.6 mM [Ca2+] as indicated on the figure. (C) Left panel: representative traces 
showing mini EJPs in Elav > Dcr, + and Elav > Dcr, pus!JRNAi. The three traces 
from each genotype are from three different larvae. Right panel: Mean mEJP 
frequency +1- SEMs (Y axis) for the indicated genotypes (X axis): Elav > Dcr, + 
and Elav > Dcr, pus!JRNAi. Recordings were collected from six different larvae from 
each genotype in HL3 solution with a bath [Ca2+] of 0.6 mM, and total number of 
responses within a one minute period were measured and averaged for each 
larva. Student T-test gave the following difference; Elav > Dcr, + vs. Elav > Dcr, 
pus!JRNAi, p<0.001. Pvalues <0.05 were considered statistically significant. 
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To understand the molecular mechanism in which Push is involved, I tried to 
identify the molecules which are up-regulated or down-regulated in the absence of 
Push. To identify proteins, I made protein extracts from wild type and push null 
mutant heads and performed 20-DIGE and mass spectrometry to identify these 
molecules (Figure 4.3. 7 A). One protein identified is Drosophila cuticular protein 
72Ec (Cpr72Ec, CG4784) (Figure 4.3.68, and table 4.3.1). In comparison 
between wild type and push null mutants, Cpr72Ec is decreased about 64% in 
push null mutants (Figure 4.3. 7C). Previous studies have reported that the mRNA 
level of Cpr72Ec is regulated by the calmodulin-binding transcription activator 
Camta (Han et al., 2006). Camta has been implicated in the regulation of Ca2+ 
homeostasis by controlling gene transcription (Han et al., 2006) as follows: The 
Ca2+/Calmodulin activation process is mediated by PLC~/ IP3R mediating 
cytoplasmic Ca2+ increase from intracellular Ca2+ storage from the endoplasmic 
reticulum (ER). The increase of intracellular [Ca2+] induces Ca2+ to bind to 
calmodulin and become an active Ca2+fcalmodulin complex. Next, Ca2+f 
calmodulin activates Camta and increase Camta-mediated gene transcription. 
The gene products of Camta will return the intracellular [Ca2+] back to normal and 
reduce the Ca2+-dependent excitotoxicity. Therefore, Camta-mediated 
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transcriptional regulation serves as a negative feedback to maintain Ca2+ 
homeostasis (Han et al., 2006). In Drosophila head protein extracts, Cpr72Ec 
showed a strong decrease in push mutants; this observation implies that protein 
expression of Camta was decreased in push null mutants, further suggesting that 
intracellular [Ca2+] in push mutants may be lower than wild type, or the ability of 
intracellular [Ca2+] is blocked. Therefore, Push may be required for Ca2+ release 
from ER, and that the cytoplasmic [Ca2+] in the neuson is important for the 
regulation of proper neurotransmitter release. 
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Figure 4.3. 7: Drosophila cuticle protein Cpr72Ec (CG487 4) is down regulated in 
push1fpush1. (A) The 20-Difference in gel electrophoresis (20-DIGE) image of 
Drosophila head protein extracts of +>+, and pusht > pusht. (B) The close view of 
region of interest (red box in (A)). Purple arrow indicated Cpr72Ec. (C) The 
analytical results that showed the different expression of Cpr72Ec between +>+, 
and pusht > pusht in Drosophila heads. 
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cuticular protein 72Ec (Drosopt1ila melanosaster) PI M.W. 
Peptide Jntormatron 5.4 50536.3 
Ca!c. Mass Actual Mass ±da ±ppm Start Seq. End Seq. Sequ£mce 
945-4496 945.52'! QJ}7t4 76 239 245 QNQREDR 
950.553 950.5222 -0,0308 -32 '118 125 LNHLNALR 
950.553 950.5222 ·0.0308 ·32 118 125 LNHLNALR 
1012.6262 1012,5949 -0.1)3'!3 *31 413 42i Tl ... RPVALSR 
1025.5351 1025.5592 -0.0259 -25 185 192 QRELNLPR 
1026.4679 1026.4391 -0Jl2B8 -28 37 44 AFYSYGYR 
'!057.575 1057.5415 .QJJ335 <3.2 309 316 QELRQOLR 
1092.5354 1092.5028 ·0.0326 ·30 175 184 AELSAMLADR 
1 i66J1052 1166.56'(7 ·0 ,0375 -32 403 4i2 YSVTTPTELR 
1221.5422 '1221 .4979 -0.0443 -36 62 72 GFYSYVDADGK 
133'! .69i4 1331.6462 ~0 .0452 -34 '13 '1 142 ALA TSLREEADR 
i 347.705 '!347.6572 -0.0478 ·35 173 184 VRAELSAMLAOR 
1376.64 13'76.595& -CUJ445 *32 338 349 QlSSDRDGODLR 
1458.7545 1458.7042 <!.0504 -35 376 387 LLEORLONSDLR 
1622.3'188 1622.8179 -0.0609 -38 388 402 VPIGAYYTLVSPNTK 
1633.8319 1633.7732 -0.0537 -36 352 366 T'VYSLAOLSSSSYLK 
1653 8442 1$53,7872 ~0.05 7 ~34 103 117 APLPVTOTEEVQQAR 
1682.?557 1682.6956 ·0.06()'1 ~3t> 37 50 AFYSYGYROENAAR 
i 6S2:.7557 '1682.6956 ·0.0601 -36 37 50 AFYSYGYRDENAAR 
'1818.9021 1818.8391 ~{LO!J3 ·35 62 77 GFYSYVDAOGKLQTVR 
1338.9607 1336.8951 .Q.0656 <36 101 117 G KAPLPVTDTEEVQQAR 
2436 2769 2436.1743 ·0 .1026 ~42 381 402 LONSDLRVP IGA YYTLVS 
Table 4.3.1: The Mass data of Cpr72Ec identification. 
Taken together, I hypothesized that push may affect neuronal transmitter 
release by blocking the elevation of intracellular calcium and altering the 
intracellular [Ca2+] in the neurons. To test this hypothesis, RNAi-mediated PLC~, 
IP3R, or Camta inhibition in neuron were performed to test the level of 
neurotransmitter release. As I expected, the EJP amplitudes were increased 
when the protein expression of PLC~, IP3R, and Camta were decreased (Figure 
4.3.8). However, the defects of knocking down the expression of PLC~. IP3R, and 
Camta are not as extreme as knocking down the expression of Push (Figure 
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4.3.8). These results indicated that push may affect neurotransmitter release 
through other regulatory mechanism, such as the PI3K and MAPK pathway. 
Therefore, characterization of other Push-mediated signaling pathways that affect 
neurotransmitter release will be the next objective. 
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Figure 4.3.8: Knocking down the expression of PLC~, IP3R, and Camta increased 
neurotransmitter release in NMJ. Left panel: representative traces showing the 
increased excitatory junction potential (EJP) amplitude in Elav > Dcr, PLCf3RNAi, 
Elav > Dcr, IP3RRNAi, and Elav > Dcr, CamfaRNAi larvae at a bath [Ca2+] of 0.6 mM 
in HL3 solution. Right panel: mean EJP amplitudes +/- SEMs (Y axis) at the bath 
of 0.6 mM [Ca2+] (X axis), from the following genotypes: Elav > Dcr, +, Elav > Dcr, 
PLCf3RNAi, Elav > Dcr, /P3RRNAi, and Elav > Dcr, CamfaRNAi_ Larval nerves were 
stimulated at a frequency of 1 Hz, and 30 responses were measured and 
averaged from each nerve. n = 11, 5, 6, 6, respectively, for each genotype in 0.6 
mM [Ca2+]. One-way ANOVA and Fisher's LSD gave the following differences at 
0.6 mM [Ca2+], respectively: for Elav > Dcr, + vs. Elav > Dcr, PLCf3RNAi, p=0.012; 
vs. Elav > Dcr, IP3RRNAi, p=0.003; Elav > Dcr, CamfaRNAi, p=0.011. P values 
<0.05 were considered statistically significant. 
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4.3.4 Push-mediated regulation of retrograde signaling may be Ca2+-dependent 
push null mutants exhibit strong phenotypes including inability to fly and an 
increase of neurotransmitter release at the larvae NMJ at low bath [Ca2+] 
(Richards et al., 1996). In section 4.3.3, I previously examined if the defect of 
neurotransmitter release was due to the loss of push-mediated intracellular [Ca2+] 
elevation. However, neuronal knockdowns of Push, PLC~. IP3R, and Camta did 
not result in a lack of flight. Therefore, I suggest that the loss of flight ability may 
not be caused solely by neurological defects but that loss of Push in glia and 
muscle might also contribute. As described above, I found that push is highly 
expressed in the Drosophila muscle and the expression pattern of Push in muscle 
is similar to that of actin filaments (Figure 4.3.4C). From these two observations, I 
hypothesize that the Drosophila flightless phenotype in push mutants may be a 
muscular defect. To test this hypothesis, we used the muscle driver Mef2 to 
express Dcr and pusf1RNAi to test whether Mef2 > Dcr. pusf1RNAi was able to knock 
down the protein expression of push in muscle. As shown on Figure 4.3.9, Mef2 > 
Dcr. pusf1RNAi was efficient in knocking down Push expression in muscle (Figure 
4.3.9). 
137 
a-push a-HRP Merge 
Mef2>Dcr, + 
Figure 4.3.9: Mef2 > Dcr, pusf1RNAI can effectively knock down the expression of 
Push in Drosophila muscle. Representative confocal images of third instar larval 
muscle of Mef2 > Dcr, +, and Mef2 > Dcr, pusf7RNAi stained with anti-Push (left 
panels), anti-HRP (middle panels), and merged images (right panels). Scale bar is 
20 J.Jm. 
Next, we found Mef2 > Dcr, pusfJRNAi adult flies exhibited the flightless 
phenotype (Table 4.3.2). These results illustrated that the flightless phenotype of 
push null mutants is due to muscular defects. Therefore, I would like to examine 
further the possible mechanism for the flightless phenotype. 
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Genotype 
lvfef2 > Dcr, + 
lvlel2 > Dcr, ,oush P:/>l•-'l 
A4el2 >Ocr; PLC /3 R.'·t:.; 
lt..Jel2 > Dcr. IP3R .R.v:..• 
A4el2 > Da. Catnta RN.:.i 
Flight Ability 
+ 
A1ef2 > Do·. mG/uR _r:;_v .::; + 
Table 4.3.2: The flight ability in the adult flies of Mef2 > Ocr, +, Mef2 > Ocr, 
pushRNAi , Mef2 > Ocr, PLCp?NAi, Mef2 > Ocr, JP3RRNAi, Mef2 > Ocr, CamfaRNAi, 
and Mef2 >Ocr, mG/uRRNAi. Flight ability is determined by following criteria. If flies 
can not escape from a plane surface within 90 sec and flies land within a circle of 
15 em radius after being dropped from a height of 1 meter, it was scored as flight 
defective (Richards et al., 1996). + indicated normal flight ability and - indicated 
flightless. 
When a neuron stimulates a target muscle, this stimulus induces calcium 
release from the muscular caz+ storage known as the Sarcoplasmic reticulum 
(SR). The increase of cytoplasmic [Ca2+] in muscle subsequently triggers the 
interaction of the myosin filaments and actin filaments to promote muscle 
contraction (Herranz et al., 2005). In addition, in section 4.3.3, I examined if Push 
is required in the regulation of Ca2+ release in neurons. In summary, I hypothesize 
that Push is similarly required in the regulation of Ca2+ release from the muscle 
SR and the alteration of the molecules that are affected by the cytoplasmic [Ca2+] 
in muscle including PLC~, IP3R, and Camta. These same molecules may also 
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regulate Drosophila flight ability. To test the possibility, I used the same muscle 
driver, Mef2-ga/4, and overexpressed Ocr with DmG/uRARNAi, PL CfJRNAi, /P3RRNAi, 
or CamfaRNAi. I found that Mef2 > Dcr, PLCf3RNAi, Mef2 > Dcr, IP3RRNAi, and Mef2 
> Dcr, CamfaRNAi adults were all flightless (Table 4.3.2). However, Mef2 > Dcr, 
DmG!uRARNAi did not show the defect in flight. These results suggested that PLCr3, 
IP3R, and Camta are required for assisting the Ca2+ release from the SR required 
for the muscle contraction and flight, but DmGiuRA is not necessary for muscle 
contraction. 
Push, PLCr3, IP3R, and Camta have been showed above that they are 
required for assisting the SR to release Ca2+ in muscle and this alteration of 
cytoplasmic [Ca2+] in muscle can also affect the presynaptic neurotransmitter 
release through a retrograde signaling pathway (Carrillo et al., 201 0; Kazama et 
al., 2007). Therefore, I suggested that knocking down protein expression of Push, 
PLC r3, IP3R, and Camta would decrease the Ca2+-dependent retrograde 
signaling and neurotransmitter release at the Drosophila NMJ. To test this 
prediction, I performed electrophysiological analysis and measured the EJP 
amplitudes in Mef2 > Dcr, pushRNAi, Mef2 > Dcr, PLCf3RNAi, Mef2 > Dcr, IP3RRNAi, 
and Mef2 > Dcr, CamfaRNAi larval NMJs. As shown in figure 4.3.9, Mef2 > Dcr, 
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pushRNAi severely reduced neurotransmitter release by about 70o/o compared to 
wild type (Figure 4.3.1 0). This result implied that Push strongly regulates 
retrograde signaling in the NMJ. I also found that the EJP amplitude in Mef2 > Dcr, 
PLCf3RNAi, Mef2 > Dcr, /P3RRNAi, and Mef2 > Dcr, CamfaRNAi larva NMJ are 
decreased about 30°/o. However, the effects of knocking down protein expression 
of PLC ~, I P3R, and Camta are not as severe as knocking down protein 
expression of Push. Therefore, these results suggested that push may partially 
control retrograde signaling, muscle contraction, and flight through the PLC~ 
/IP3R-mediated Ca2+ signaling pathway but remain further characterized. 
Furthermore, EJP amplitude in Mef2 > Dcr, DmG/uRARNAi larvae remains the 
same as wild type for the supporting the hypothesis that DmGiuRA does not 
participate in retrograde signaling (Figure 4.3.1 0). For the supporting the 
hypothesis that DmGiuRA does not participate in retrograde signaling. 
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Figure 4.3.1 0: Knocking down the expression of Push, PLC~, IP3R, and Camta in 
Drosophila muscle decreased neurotransmitter release. Left panel: representative 
traces showing the decreased excitatory junction potential (EJP) amplitude in 
Mef2 > Dcr, pushRNAi, Mef2 > Dcr, PLCfJRNAi, Mef2 > Dcr, IP3RRNAi, and Mef2 > 
Dcr, CamfaRNAi larvae at a bath [Ca2+] of 0.6 mM in HL3 solution. Right panel: 
mean EJP amplitudes +/- SEMs (Y axis) at the bath of 0.6 mM [Ca2+] (X axis), 
from the following genotypes: Mef2 > Dcr, +, Mef2 > Dcr, PLCf3RNAi, Mef2 > Dcr, 
PLCf3RNAi, Mef2 > Dcr, /P3RRNAi, and Mef2 > Dcr, CamfaRNAi_ Larval nerves were 
stimulated at a frequency of 1 Hz, and 30 responses were measured and 
averaged from each nerve. n = 12, 8, 7, 5, 7, 6, respectively, for each genotype in 
0.6 mM [Ca2+]. One-way ANOVA and Fisher's LSD gave the following differences 
at 0.6 mM [Ca2+], respectively: for Mef2 > Dcr, + vs. Mef2 > Dcr, pushRNAi, 
p<0.001; vs. Mef2 > Dcr, PLCf3RNAi, p=0.015; vs. Mef2 > Dcr, IPJRRNAi, p=0.004; 
vs. Elav > Dcr, CamfaRNAi, p=0.004; vs. Elav > Dcr, mG/uRRNAi, p=0.77. Pvalues 
<0.05 were considered statistically significant. 
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Because Mef2 > Dcr, pusf1RNAi exhibited severe decreases in retrograde 
signaling and neurotransmitter release compared to the of PLC~. IP3R, and 
Camta knockdown (Figure 4.3.1 0), Push may regulate retrograde signaling 
through PLC~/IP3R-independent pathway. Therefore, I tested if Push regulated 
retrograde signaling through the bone morphogenetic protein (BMP) signaling 
pathway. As mentioned in Section 1.9, the BMP signaling pathway is the most 
well-established system for regulating retrograde signaling in Drosophila NMJ. If 
Push regulates retrograde signaling through the BMP signaling pathway in 
addition to Ca2+ pathway, level of phosphorylated Smad in motor neuron will be 
altered. As shown on Figure 4.3.11, the basal phospho-Smad (p-Smad) level in 
Mef2 > Dcr, + and Mef2 > Dcr, pusf1RNAi exhibited no significant differences. 
These results suggested that Push does not regulate retrograde signaling through 
the BMP signaling pathway. Therefore, the retrograde signaling pathways 
affected by Push remain unidentified. 
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a-p-Smad a-HRP Merge 
Figure 4.3.11: Mef2 > De~; pusiJRNAi did not affect p-Smad level in Drosophila 
nerve terminal. Representative confocal images of of third instar larval muscle of 
Mef2 > Dcr, + and Mef2 > Dcr, pus!JRNAi stained with anti-p-Smad (left panels), 
anti-HRP (middle panels), and merged images (right panels). Scale bar is 5 ~m. 
4.4 Summary 
In both Drosophila and mammalian system, push has been implicated in the 
regulation of neurotransmitter release (Richards et al., 1996), chromatin 
scaffolding, spermatogenesis (Richards et al., 1996), and perineurial glia growth 
(Yager et al., 2001). However, mechanisms by which Push affects these 
processes have not been elucidated. Here I reported several novel observations. 
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First, I found that push is highly expressed in neurons, muscle, and glia cells. 
Second, I find that push acts both in neuron and muscle to regulate 
neurotransmitter release. Third, the flightless phenotype of push mutants can be 
phenocopied by RNAi knockdown of PLC j3/IP3R-mediated Ca2+ signaling 
molecules. Fourth, from immunostaining of Drosophila S2 cells and muscles, I 
found that push is localized similar to microtubules and actin filaments. Finally, the 
mammalian ortholog of push, P600, has been regulated to be an ER-associated 
and 26S proteasome-associated protein (Besche et al., 2009; Shim et al., 2008). 
Taken together, these results suggest that push may function as a platform that 
connects the cytoskeleton (microtubules and actin filaments), Ca2+ storage (ER 
and SR), and the proteasome in the nervous and muscular system (Figure 4.4.1 ). 
This biological setting of Push may provide several advantages: 1) ERs or SRs 
can be located close to the regions that utilize changes in [Ca2+] as signals; 2) 
Ca2+ can diffuse to target faster and be utilized more efficiently; 3) push may also 
act as a Ca2+ sensor because of the Ca2+/CaM binding property of Push and 
negative regulator to control the intracellular Ca2+ homeostasis; 4) abnormal Ca2+ 
concentration can be rectified faster by UPS-mediated protein degradation and no 
transcriptional and translational machinery is needed. These results provide novel 
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insights into the observation by which push may control the intracellular [Ca2+] 
release in Drosophila motor neurons and muscle. Here, I propose a possible 
working mechanism of Drosophila Push (Figure 4.4.1 ). Under normal conditions, 
Push and its UPS machinery negatively regulate the unknown protein which 
inhibits Ca2+ release. When PLCI3/IP3R-mediated Ca2+ signaling pathway induces 
Ca2+ release and increases intracellular [Ca2+], the active Ca2+/CaM binds to Push 
directly and inhibits the Push-mediated UPS machinery. This inhibition prevents 
the degradation of the unknown protein and allows this protein to inhibit Ca2+ 
release from Ca2+ storage. Then, the cell can adjust intracellular [Ca2+] back to 
normal by pumping Ca2+ back to Ca2+ storage (Figure 4.4.1 ). In addition, in Camta 
knockdown mutants, the Camta-mediated negative feedback control of [Ca2+] is 
damaged and results in the elevation of intracellular [Ca2+]. The elevation of 
intracellular [Ca2+] inhibits of Push activity and prevents of the degradation of 
unknown protetin. Therefore, the unknown protein may block the elevation of 
[Ca2+] and result lower intracellular [Ca2+). In conclusion, the Push-mediated UPS 
machinery may play as negative feedback in the regulation of intracellular [Ca2+] 
in neuron and muscle. 
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CaM 
IP3 
ER or SR 
• 
protein 
(membrane or soluble protein) 
Figure 4.4.1: The role of Push in the regulation of intracellular [Ca2+]. When 
intracellu lar [Ca2+] is increased, the active Ca2+/CaM will bind to Push directly and 
inhibit Push-mediated UPS machinery to prevent the degradation of unknown 
protein. This inhibition allows unknown protein to inhibit more Ca2+ release form 
Ca2+ storage. Then, the cell can adjust intracellular [Ca2+] back to normal and 
maintain Ca2+ homeostasis. 
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4.5 Future Work 
4.5.1 Identify any Push-related protein degradation substrates 
E3-ubiquitin ligases, collaborating with E1-ubiquitin activating and E2-ubquitin 
conjugating enzymes, can label specific proteins with a ubiquitin degradation 
signal and further degrade those proteins via the proteasome-mediated 
degradation pathway (Glickman and Ciechanover, 2002; Hershko and 
Ciechanover, 1998). Push has been predicted to be an E3-ubiquitin ligase (Yager 
et al., 2001), but Push-mediated protein degradation still remains unknown. To 
understand this degradation mechanism, the E1-ubiquitin activating, E2-ubquitin 
conjugating, and target proteins need to be identified. Therefore, I will perform 
Tandem affinity purification (TAP) (details are described in Chapter 6) and mass 
spectrometry to identify Push substrates. To carry out the TAP experiment on 
Push, generating a transgenic fly which possesses a TAP-tagged push is required 
(details are described in Chapter 6). 
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Chapter 6: Appendices 
6.1 The push-CTAGtransgenic fly. 
Tandem affinity purification (TAP) is a tool that uses a target protein as bait to 
fish out substrate proteins under native conditions (Chang, 2006; Gingras et al., 
2005). The TAP tag contains other lgG binding domain of Staphylococcus aureus 
protein A (ProtA) and a calmodulin binding peptide (CBP) (Chang, 2006; Gingras 
et al., 2005). This method involves the fusion of the TAP tag to the target protein 
and expression of this fusion protein in the cell or organism. The protein complex 
is purified by two different affinity columns; the first one is lgG and the second one 
is calmodulin. Then, the bound proteins are analyzed by electrophoresis and 
identified by mass spectrometry (Puig et al., 2001). As mentioned in Section 4.5, I 
want to identify the Push binding substrates. Therefore, generating transgenic 
flies which possess a TAP-tagged Push is required. 
To make the TAP-tagged Push construct, we used the P[acman] plasmid 
(provided by Hugo Sellen, Ph.D. , BCM) (Venken et al., 2006). The P[acman] 
plasmid contains two origins of replication. One origin, oriS, which is of 
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low-copy-number can stabilize a large cloned DNA fragment, such as the bacteria 
artificial chromosome (BAC) and prevent the errors of DNA replication (Shizuya et 
al., 1992). The other origin ,oriV, which is of high-copy-number, provides the 
capacity for sequencing, embryo injection, and other manipulations requiring large 
amounts of plasmid DNA (Venken and Sellen, 2005; Venken et al., 2006; Wild et 
al., 2002). Therefore, P[acman] is capable to carry large push genomic DNA and 
20 kb upstream region, which equates to 45 kb. In addition, we wanted to keep 
the N-terminal signal sequence of Push to ensure that Push can be properly 
inserted into the membrane. Therefore, I cloned the C-terminal TAP tag ( CTAG) 
DNA fragment from pFA-6A-CTAP plasmid (provided by Kathy L. Gould, Ph.D, 
Vanderbilt University) and I cloned two DNA fragments of push (LA and RA, each 
is about 500 bp) from BAC clone (BACROB/01, CHORI) which carries push 
(Figure 6.1.1 ). Then, LA, RA, and CTAG were cloned into P[acman] (called 
P[acman]-LRC). P[acman]-LRC was co-transformed with BACROB/01 into the E. 
coli strain SW1 02 (provided by NCI). This transformation in SW1 02 induced 
phage-mediated recombination and generated P[acman] with push and CTAG 
(P[acman]-push-CTAG). The P[acman]-push-CTAG was further characterized by 
plasmid size, PCR, and restriction enzyme digestion mapping to ensure the 
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construct was correct (Figure 6.1.2). The correct P[acman]-push-CTAG was 
injected into Drosophila embryo (white-). The successful transgenic push-CTAG 
flies were screened and selected according to their red eye color (white+) (Figure 
6.1.1 ). 
P[acman]-push-LRC 
BAC: BACR08101 
J Gap repair 
'<' 
P[acman]-push-CTAG 
White· ··I 
I t ·· 
Whire '" 
Figure 6.1.1: The cloning strategy of P[acman]-push-CTAG. LA, RA, and CTAG 
were cloned into P[acman] (called P[acman]-LRC). Linear P[acman]-LRC was 
co-transformed with BACROB/01 into the E. coli strain SW1 02. The 
phage-mediated homologous recombination (gap repair) in SW1 02 generated 
P[acman] with push and CTAG (P[acman]-push-CTAG). The P[acman]-push-
CTAG was injected into Drosophila embryo with white- background. The 
successful transgenic push-CTAG flies were screened and selected according to 
their red eye color (white+) 
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Figure 6.1.2: The characterization of P[acman]-push-CTAG. (A) Top: the simple 
picture shows the region of push-CT AG in P[acman]-push-CTAG. Bottom left: the 
DNA electrophoresis shows the size of P[acman]-push-CTAG. Bottom right: the 
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DNA electrophoresis shows the PCR products (CTAG, A, 8, C, C-L, and C-R) 
were amplified from different region of P[acman]-push-CTAG. These DNA 
fragments (CTAG, A, 8, C, C-L, and C-R) are indicated on Top picture. (8) Left: 
the simple picture shows the size of DNA fragments after restriction enzymes 
(Asc I and Asi Sl) digestion. Right: the Asc 1/Asi Sl digestion map of 
P[acman]-push- CTAG. Each arrow indicated the fragment size and parentheses 
represent the related pair of restriction enzymes. 2-Log DNA ladder and Lambda 
DNA Hindlll digest are DNA markers. 
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